###begin article-title 0
Strong Evidence of a Combination Polymorphism of the Tyrosine Kinase 2 Gene and the Signal Transducer and Activator of Transcription 3 Gene as a DNA-Based Biomarker for Susceptibility to Crohn's Disease in the Japanese Population
###end article-title 0
###begin title 1
Objective
###end title 1
###begin p 2
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
An association between susceptibility to inflammatory bowel disease (IBD) and polymorphisms of both the tyrosine kinase 2 gene (TYK2) and the signal transducer and activator of transcription 3 gene (STAT3) was examined in a Japanese population in order to identify the genetic determinants of IBD.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
The study subjects comprised 112 patients with ulcerative colitis, 83 patients with Crohn's disease (CD), and 200 healthy control subjects. Seven tag single-nucleotide polymorphisms (SNPs) in TYK2 and STAT3 were detected by PCR-restriction fragment length polymorphism.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 476 477 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 573 578 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 612 616 612 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 729 730 729 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
###xml 409 417 <span type="species:ncbi:9606">patients</span>
The frequencies of a C allele and its homozygous C/C genotype at rs2293152 SNP in STAT3 in CD patients were significantly higher than those in control subjects (P = 0.007 and P = 0.001, respectively). Furthermore, out of four haplotypes composed of the two tag SNPs (rs280519 and rs2304256) in TYK2, the frequencies of a Hap 1 haplotype and its homozygous Hap 1/Hap1 diplotype were significantly higher in CD patients in comparison to those in control subjects (P = 0.023 and P = 0.024, respectively). In addition, the presence of both the C/C genotype at rs2293152 SNP in STAT3 and the Hap 1/Hap 1 diplotype of TYK2 independently contributes to the pathogenesis of CD and significantly increases the odds ratio to 7.486 for CD (P = 0.0008).
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
TYK2 and STAT3 are genetic determinants of CD in the Japanese population. This combination polymorphism may be useful as a new genetic biomarker for the identification of high-risk individuals susceptible to CD.
###end p 8
###begin title 9
Keywords
###end title 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 603 604 603 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 605 606 605 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 859 860 859 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
Idiopathic inflammatory bowel disease (IBD) is a multifactorial disorder characterized by chronic and relapsing inflammation specific to the gastrointestinal tract, thus resulting in intestinal malabsorption, mucosal immune system abnormalities, and exaggerated inflammatory responses [1-5]. IBD has two main subtypes, namely ulcerative colitis (UC) and Crohn's disease (CD). Although the precise etiology remains unknown, several environmental factors, such as commensal bacteria, food antigens, and smoking, as well as multiple genetic factors may contribute to the occurrence and development of IBD [1-5]. Genome-wide linkage-based family studies, candidate gene-based association studies, and large-scale genome-wide association (GWA) studies using single-nucleotide polymorphisms (SNPs) have shown possible IBD susceptibility genes and chromosomal loci [6-10].
###end p 11
###begin p 12
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 966 974 <span type="species:ncbi:9606">patients</span>
IBD is involved in a complex interplay of innate and adaptive immune cells, including lymphocytes, macrophages, and dendritic cells. In such a setting, alterations in cytokine synthesis and cytokine signaling pathways are attributed to the pathogenesis of IBD [1-5]. GWA studies have recently indicated that the multiple genes implicated in the interleukin 23 (IL-23) and its receptor (IL23R) signaling pathway are associated with susceptibility to CD as well as UC [6-12]. For example, IL-23, IL23R, interleukin 12 precursor (IL12B), interleukin 12 receptor (IL12R), the Janus kinase (JAK) families, and the signal transducers and activators of transcription (STAT) families belong to a gene network in the IL-23/IL23R signaling pathway [13], implying that a subset of these genes can play a central role in the pathogenesis of IBD and may function as a key conductor of innate and adaptive inflammatory responses at multiple levels in the intestinal mucosa of IBD patients.
###end p 12
###begin p 13
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-23</italic>
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAK2</italic>
###xml 23 24 23 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 26 28 26 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 41 42 41 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 44 46 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAK2</italic>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 458 459 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 461 463 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 464 466 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 515 517 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 589 591 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 833 835 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 836 838 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 1017 1018 1014 1015 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1035 1036 1032 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1046 1048 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 1049 1051 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1124 1125 1121 1122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1159 1161 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 1163 1165 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 1166 1168 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1256 1258 1253 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
IL-23 as well as JAK2 [9, 14] and STAT3 [9, 12, 14] are associated with susceptibility to CD. These genes are involved in a gene network in the IL23/IL23R signaling pathway. JAK2 has been recently identified as a CD susceptibility gene in a meta-analysis of GWA data [9, 14] but not by any single-marker association studies on CD. Likewise, tyrosine kinase 2 (TYK2), which is a member of the JAK families located in beta1 subunit of IL12 receptor (IL12RB1) [4, 15-17] and in gp130 of interleukin 6 receptor (IL6R) [18], is also identified as a CD susceptibility gene by the meta-analysis [10] but did not reach significance by single-marker association studies. Furthermore, TYK2 is activated via signaling from a broader range of cytokine receptors and induces phosphorylation, homodimerization, and nuclear translocation of STAT3 [15-19], thus resulting in several gene transcriptions and leading to IL-23-induced production of IL-17, a pro-inflammatory cytokine in natural killer cells, natural killer T cells, CD4+ T cells, and CD8+ T cells [20-22]. This signaling cascade also plays a role in the differentiation of CD4+ (naive) T cells into Th17 cells [17, 20-22], which is involved in the first line of host defense by controlling immune responses [22].
###end p 13
###begin p 14
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 257 262 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
Therefore, we performed a candidate gene-based association study by selecting TYK2 and STAT3 as candidate genes. The purpose of this study was to investigate whether SNPs and their combination polymorphisms, which are referred to as haplotypes, in TYK2 and STAT3 are also associated with susceptibility to IBD in a Japanese population and whether such polymorphisms can be used as new genetic biomarkers for predicting the onset of IBD.
###end p 14
###begin title 15
Subjects and Methods
###end title 15
###begin title 16
Subjects
###end title 16
###begin p 17
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">I</xref>
###xml 605 612 605 612 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table I</label>
###xml 612 658 612 658 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="18">The Clinical Characteristics of Study Subjects</p>
###xml 612 658 612 658 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="18">The Clinical Characteristics of Study Subjects</p></caption>
###xml 658 673 658 673 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Characteristics</th>
###xml 673 686 673 686 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Patients with</th>
###xml 686 702 686 702 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Control subjects</th>
###xml 658 702 658 702 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">Characteristics</th><th colspan="2">Patients with</th><th rowspan="2">Control subjects</th></tr>
###xml 702 704 702 704 <th xmlns:xlink="http://www.w3.org/1999/xlink">UC</th>
###xml 704 706 704 706 <th xmlns:xlink="http://www.w3.org/1999/xlink">CD</th>
###xml 702 706 702 706 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>UC</th><th>CD</th></tr>
###xml 658 706 658 706 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">Characteristics</th><th colspan="2">Patients with</th><th rowspan="2">Control subjects</th></tr><tr><th>UC</th><th>CD</th></tr></thead>
###xml 706 712 706 712 <td xmlns:xlink="http://www.w3.org/1999/xlink">Number</td>
###xml 712 715 712 715 <td xmlns:xlink="http://www.w3.org/1999/xlink">114</td>
###xml 715 717 715 717 <td xmlns:xlink="http://www.w3.org/1999/xlink">83</td>
###xml 717 720 717 720 <td xmlns:xlink="http://www.w3.org/1999/xlink">200</td>
###xml 706 720 706 720 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Number</td><td>114</td><td>83</td><td>200</td></tr>
###xml 720 744 720 742 <td xmlns:xlink="http://www.w3.org/1999/xlink">Age, mean&#8201;&#177;&#8201;SD (years)</td>
###xml 744 758 742 754 <td xmlns:xlink="http://www.w3.org/1999/xlink">44.2&#8201;&#177;&#8201;16.7*</td>
###xml 758 771 754 765 <td xmlns:xlink="http://www.w3.org/1999/xlink">34.3&#8201;&#177;&#8201;12.5</td>
###xml 771 784 765 776 <td xmlns:xlink="http://www.w3.org/1999/xlink">32.5&#8201;&#177;&#8201;11.2</td>
###xml 720 784 720 776 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Age, mean&#8201;&#177;&#8201;SD (years)</td><td>44.2&#8201;&#177;&#8201;16.7*</td><td>34.3&#8201;&#177;&#8201;12.5</td><td>32.5&#8201;&#177;&#8201;11.2</td></tr>
###xml 784 801 776 793 <td xmlns:xlink="http://www.w3.org/1999/xlink">Age range (years)</td>
###xml 801 806 793 798 <td xmlns:xlink="http://www.w3.org/1999/xlink">14&#8211;83</td>
###xml 806 811 798 803 <td xmlns:xlink="http://www.w3.org/1999/xlink">17&#8211;75</td>
###xml 811 816 803 808 <td xmlns:xlink="http://www.w3.org/1999/xlink">20&#8211;60</td>
###xml 784 816 776 808 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Age range (years)</td><td>14&#8211;83</td><td>17&#8211;75</td><td>20&#8211;60</td></tr>
###xml 816 831 808 823 <td xmlns:xlink="http://www.w3.org/1999/xlink">Male/female (%)</td>
###xml 831 848 823 840 <td xmlns:xlink="http://www.w3.org/1999/xlink">59/55 (51.7/48.3)</td>
###xml 848 865 840 857 <td xmlns:xlink="http://www.w3.org/1999/xlink">50/33 (60.2/39.8)</td>
###xml 865 883 857 875 <td xmlns:xlink="http://www.w3.org/1999/xlink">126/74 (62.5/37.5)</td>
###xml 816 883 808 875 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Male/female (%)</td><td>59/55 (51.7/48.3)</td><td>50/33 (60.2/39.8)</td><td>126/74 (62.5/37.5)</td></tr>
###xml 883 895 875 887 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="4">Age at onset</td>
###xml 883 895 875 887 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="4">Age at onset</td></tr>
###xml 895 907 887 897 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;&#8804;40&#160;years</td>
###xml 907 909 897 899 <td xmlns:xlink="http://www.w3.org/1999/xlink">39</td>
###xml 909 911 899 901 <td xmlns:xlink="http://www.w3.org/1999/xlink">11</td>
###xml 911 911 901 901 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 895 911 887 901 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;&#8804;40&#160;years</td><td>39</td><td>11</td><td/></tr>
###xml 911 923 901 911 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;&#8805;40&#160;years</td>
###xml 923 925 911 913 <td xmlns:xlink="http://www.w3.org/1999/xlink">75</td>
###xml 925 927 913 915 <td xmlns:xlink="http://www.w3.org/1999/xlink">72</td>
###xml 927 927 915 915 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 911 927 901 915 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;&#8805;40&#160;years</td><td>75</td><td>72</td><td/></tr>
###xml 927 939 915 927 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="4">Extent of UC</td>
###xml 927 939 915 927 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="4">Extent of UC</td></tr>
###xml 939 949 927 937 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Proctitis</td>
###xml 949 951 937 939 <td xmlns:xlink="http://www.w3.org/1999/xlink">14</td>
###xml 951 951 939 939 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 951 951 939 939 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 939 951 927 939 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Proctitis</td><td>14</td><td/><td/></tr>
###xml 951 970 939 958 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Left-sided colitis</td>
###xml 970 972 958 960 <td xmlns:xlink="http://www.w3.org/1999/xlink">43</td>
###xml 972 972 960 960 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 972 972 960 960 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 951 972 939 960 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Left-sided colitis</td><td>43</td><td/><td/></tr>
###xml 972 983 960 971 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Pancolitis</td>
###xml 983 985 971 973 <td xmlns:xlink="http://www.w3.org/1999/xlink">57</td>
###xml 985 985 973 973 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 985 985 973 973 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 972 985 960 973 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Pancolitis</td><td>57</td><td/><td/></tr>
###xml 985 999 973 987 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="4">Location of CD</td>
###xml 985 999 973 987 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="4">Location of CD</td></tr>
###xml 999 1005 987 993 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Ileal</td>
###xml 1005 1005 993 993 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1005 1007 993 995 <td xmlns:xlink="http://www.w3.org/1999/xlink">16</td>
###xml 1007 1007 995 995 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 999 1007 987 995 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Ileal</td><td/><td>16</td><td/></tr>
###xml 1007 1019 995 1007 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Ileocolonic</td>
###xml 1019 1019 1007 1007 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1019 1021 1007 1009 <td xmlns:xlink="http://www.w3.org/1999/xlink">55</td>
###xml 1021 1021 1009 1009 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1007 1021 995 1009 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Ileocolonic</td><td/><td>55</td><td/></tr>
###xml 1021 1029 1009 1017 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Colonic</td>
###xml 1029 1029 1017 1017 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1029 1031 1017 1019 <td xmlns:xlink="http://www.w3.org/1999/xlink">11</td>
###xml 1031 1031 1019 1019 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1021 1031 1009 1019 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Colonic</td><td/><td>11</td><td/></tr>
###xml 1031 1046 1019 1034 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Isolated upper</td>
###xml 1046 1046 1034 1034 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1046 1047 1034 1035 <td xmlns:xlink="http://www.w3.org/1999/xlink">1</td>
###xml 1047 1047 1035 1035 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1031 1047 1019 1035 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Isolated upper</td><td/><td>1</td><td/></tr>
###xml 1047 1063 1035 1051 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="4">Disease severity</td>
###xml 1047 1063 1035 1051 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="4">Disease severity</td></tr>
###xml 1063 1068 1051 1056 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Mild</td>
###xml 1068 1070 1056 1058 <td xmlns:xlink="http://www.w3.org/1999/xlink">51</td>
###xml 1070 1072 1058 1060 <td xmlns:xlink="http://www.w3.org/1999/xlink">17</td>
###xml 1072 1072 1060 1060 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1063 1072 1051 1060 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Mild</td><td>51</td><td>17</td><td/></tr>
###xml 1072 1081 1060 1069 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Moderate</td>
###xml 1081 1083 1069 1071 <td xmlns:xlink="http://www.w3.org/1999/xlink">38</td>
###xml 1083 1085 1071 1073 <td xmlns:xlink="http://www.w3.org/1999/xlink">45</td>
###xml 1085 1085 1073 1073 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1072 1085 1060 1073 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Moderate</td><td>38</td><td>45</td><td/></tr>
###xml 1085 1092 1073 1080 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Severe</td>
###xml 1092 1094 1080 1082 <td xmlns:xlink="http://www.w3.org/1999/xlink">21</td>
###xml 1094 1095 1082 1083 <td xmlns:xlink="http://www.w3.org/1999/xlink">9</td>
###xml 1095 1095 1083 1083 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1085 1095 1073 1083 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Severe</td><td>21</td><td>9</td><td/></tr>
###xml 1095 1103 1083 1091 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Unknown</td>
###xml 1103 1104 1091 1092 <td xmlns:xlink="http://www.w3.org/1999/xlink">4</td>
###xml 1104 1106 1092 1094 <td xmlns:xlink="http://www.w3.org/1999/xlink">12</td>
###xml 1106 1106 1094 1094 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1095 1106 1083 1094 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Unknown</td><td>4</td><td>12</td><td/></tr>
###xml 1106 1122 1094 1110 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="4">Disease activity</td>
###xml 1106 1122 1094 1110 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="4">Disease activity</td></tr>
###xml 1122 1129 1110 1117 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Active</td>
###xml 1129 1131 1117 1119 <td xmlns:xlink="http://www.w3.org/1999/xlink">63</td>
###xml 1131 1133 1119 1121 <td xmlns:xlink="http://www.w3.org/1999/xlink">54</td>
###xml 1133 1133 1121 1121 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1122 1133 1110 1121 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Active</td><td>63</td><td>54</td><td/></tr>
###xml 1133 1142 1121 1130 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Inactive</td>
###xml 1142 1144 1130 1132 <td xmlns:xlink="http://www.w3.org/1999/xlink">48</td>
###xml 1144 1146 1132 1134 <td xmlns:xlink="http://www.w3.org/1999/xlink">17</td>
###xml 1146 1146 1134 1134 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1133 1146 1121 1134 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Inactive</td><td>48</td><td>17</td><td/></tr>
###xml 1146 1154 1134 1142 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Unknown</td>
###xml 1154 1155 1142 1143 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 1155 1157 1143 1145 <td xmlns:xlink="http://www.w3.org/1999/xlink">12</td>
###xml 1157 1157 1145 1145 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1146 1157 1134 1145 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Unknown</td><td>3</td><td>12</td><td/></tr>
###xml 1171 1172 1159 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1157 1172 1145 1160 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="4">Behavior of CD<sup>a</sup></td>
###xml 1157 1172 1145 1160 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="4">Behavior of CD<sup>a</sup></td></tr>
###xml 1172 1184 1160 1172 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Stricturing</td>
###xml 1184 1184 1172 1172 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1184 1186 1172 1174 <td xmlns:xlink="http://www.w3.org/1999/xlink">44</td>
###xml 1186 1186 1174 1174 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1172 1186 1160 1174 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Stricturing</td><td/><td>44</td><td/></tr>
###xml 1186 1198 1174 1186 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Penetrating</td>
###xml 1198 1198 1186 1186 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1198 1200 1186 1188 <td xmlns:xlink="http://www.w3.org/1999/xlink">40</td>
###xml 1200 1200 1188 1188 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1186 1200 1174 1188 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Penetrating</td><td/><td>40</td><td/></tr>
###xml 1200 1218 1188 1206 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Perianal diseases</td>
###xml 1218 1218 1206 1206 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1218 1220 1206 1208 <td xmlns:xlink="http://www.w3.org/1999/xlink">36</td>
###xml 1220 1220 1208 1208 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1200 1220 1188 1208 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Perianal diseases</td><td/><td>36</td><td/></tr>
###xml 706 1220 706 1208 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>Number</td><td>114</td><td>83</td><td>200</td></tr><tr><td>Age, mean&#8201;&#177;&#8201;SD (years)</td><td>44.2&#8201;&#177;&#8201;16.7*</td><td>34.3&#8201;&#177;&#8201;12.5</td><td>32.5&#8201;&#177;&#8201;11.2</td></tr><tr><td>Age range (years)</td><td>14&#8211;83</td><td>17&#8211;75</td><td>20&#8211;60</td></tr><tr><td>Male/female (%)</td><td>59/55 (51.7/48.3)</td><td>50/33 (60.2/39.8)</td><td>126/74 (62.5/37.5)</td></tr><tr><td colspan="4">Age at onset</td></tr><tr><td>&#160;&#8804;40&#160;years</td><td>39</td><td>11</td><td/></tr><tr><td>&#160;&#8805;40&#160;years</td><td>75</td><td>72</td><td/></tr><tr><td colspan="4">Extent of UC</td></tr><tr><td>&#160;Proctitis</td><td>14</td><td/><td/></tr><tr><td>&#160;Left-sided colitis</td><td>43</td><td/><td/></tr><tr><td>&#160;Pancolitis</td><td>57</td><td/><td/></tr><tr><td colspan="4">Location of CD</td></tr><tr><td>&#160;Ileal</td><td/><td>16</td><td/></tr><tr><td>&#160;Ileocolonic</td><td/><td>55</td><td/></tr><tr><td>&#160;Colonic</td><td/><td>11</td><td/></tr><tr><td>&#160;Isolated upper</td><td/><td>1</td><td/></tr><tr><td colspan="4">Disease severity</td></tr><tr><td>&#160;Mild</td><td>51</td><td>17</td><td/></tr><tr><td>&#160;Moderate</td><td>38</td><td>45</td><td/></tr><tr><td>&#160;Severe</td><td>21</td><td>9</td><td/></tr><tr><td>&#160;Unknown</td><td>4</td><td>12</td><td/></tr><tr><td colspan="4">Disease activity</td></tr><tr><td>&#160;Active</td><td>63</td><td>54</td><td/></tr><tr><td>&#160;Inactive</td><td>48</td><td>17</td><td/></tr><tr><td>&#160;Unknown</td><td>3</td><td>12</td><td/></tr><tr><td colspan="4">Behavior of CD<sup>a</sup></td></tr><tr><td>&#160;Stricturing</td><td/><td>44</td><td/></tr><tr><td>&#160;Penetrating</td><td/><td>40</td><td/></tr><tr><td>&#160;Perianal diseases</td><td/><td>36</td><td/></tr></tbody>
###xml 658 1220 658 1208 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">Characteristics</th><th colspan="2">Patients with</th><th rowspan="2">Control subjects</th></tr><tr><th>UC</th><th>CD</th></tr></thead><tbody><tr><td>Number</td><td>114</td><td>83</td><td>200</td></tr><tr><td>Age, mean&#8201;&#177;&#8201;SD (years)</td><td>44.2&#8201;&#177;&#8201;16.7*</td><td>34.3&#8201;&#177;&#8201;12.5</td><td>32.5&#8201;&#177;&#8201;11.2</td></tr><tr><td>Age range (years)</td><td>14&#8211;83</td><td>17&#8211;75</td><td>20&#8211;60</td></tr><tr><td>Male/female (%)</td><td>59/55 (51.7/48.3)</td><td>50/33 (60.2/39.8)</td><td>126/74 (62.5/37.5)</td></tr><tr><td colspan="4">Age at onset</td></tr><tr><td>&#160;&#8804;40&#160;years</td><td>39</td><td>11</td><td/></tr><tr><td>&#160;&#8805;40&#160;years</td><td>75</td><td>72</td><td/></tr><tr><td colspan="4">Extent of UC</td></tr><tr><td>&#160;Proctitis</td><td>14</td><td/><td/></tr><tr><td>&#160;Left-sided colitis</td><td>43</td><td/><td/></tr><tr><td>&#160;Pancolitis</td><td>57</td><td/><td/></tr><tr><td colspan="4">Location of CD</td></tr><tr><td>&#160;Ileal</td><td/><td>16</td><td/></tr><tr><td>&#160;Ileocolonic</td><td/><td>55</td><td/></tr><tr><td>&#160;Colonic</td><td/><td>11</td><td/></tr><tr><td>&#160;Isolated upper</td><td/><td>1</td><td/></tr><tr><td colspan="4">Disease severity</td></tr><tr><td>&#160;Mild</td><td>51</td><td>17</td><td/></tr><tr><td>&#160;Moderate</td><td>38</td><td>45</td><td/></tr><tr><td>&#160;Severe</td><td>21</td><td>9</td><td/></tr><tr><td>&#160;Unknown</td><td>4</td><td>12</td><td/></tr><tr><td colspan="4">Disease activity</td></tr><tr><td>&#160;Active</td><td>63</td><td>54</td><td/></tr><tr><td>&#160;Inactive</td><td>48</td><td>17</td><td/></tr><tr><td>&#160;Unknown</td><td>3</td><td>12</td><td/></tr><tr><td colspan="4">Behavior of CD<sup>a</sup></td></tr><tr><td>&#160;Stricturing</td><td/><td>44</td><td/></tr><tr><td>&#160;Penetrating</td><td/><td>40</td><td/></tr><tr><td>&#160;Perianal diseases</td><td/><td>36</td><td/></tr></tbody></table>
###xml 1220 1222 1208 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SD</italic>
###xml 1220 1241 1208 1229 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="19"><italic>SD</italic> standard deviation</p>
###xml 1242 1243 1230 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1241 1284 1229 1272 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="20">*<italic>P</italic>&#8201;&lt;&#8201;0.01 in comparison to control subjects</p>
###xml 1284 1285 1272 1273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1284 1324 1272 1312 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="21"><sup>a</sup>Number of the affected patients with CD</p>
###xml 1220 1324 1208 1312 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="19"><italic>SD</italic> standard deviation</p><p textid="20">*<italic>P</italic>&#8201;&lt;&#8201;0.01 in comparison to control subjects</p><p textid="21"><sup>a</sup>Number of the affected patients with CD</p></table-wrap-foot>
###xml 605 1324 605 1312 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table I</label><caption><p textid="18">The Clinical Characteristics of Study Subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Characteristics</th><th colspan="2">Patients with</th><th rowspan="2">Control subjects</th></tr><tr><th>UC</th><th>CD</th></tr></thead><tbody><tr><td>Number</td><td>114</td><td>83</td><td>200</td></tr><tr><td>Age, mean&#8201;&#177;&#8201;SD (years)</td><td>44.2&#8201;&#177;&#8201;16.7*</td><td>34.3&#8201;&#177;&#8201;12.5</td><td>32.5&#8201;&#177;&#8201;11.2</td></tr><tr><td>Age range (years)</td><td>14&#8211;83</td><td>17&#8211;75</td><td>20&#8211;60</td></tr><tr><td>Male/female (%)</td><td>59/55 (51.7/48.3)</td><td>50/33 (60.2/39.8)</td><td>126/74 (62.5/37.5)</td></tr><tr><td colspan="4">Age at onset</td></tr><tr><td>&#160;&#8804;40&#160;years</td><td>39</td><td>11</td><td/></tr><tr><td>&#160;&#8805;40&#160;years</td><td>75</td><td>72</td><td/></tr><tr><td colspan="4">Extent of UC</td></tr><tr><td>&#160;Proctitis</td><td>14</td><td/><td/></tr><tr><td>&#160;Left-sided colitis</td><td>43</td><td/><td/></tr><tr><td>&#160;Pancolitis</td><td>57</td><td/><td/></tr><tr><td colspan="4">Location of CD</td></tr><tr><td>&#160;Ileal</td><td/><td>16</td><td/></tr><tr><td>&#160;Ileocolonic</td><td/><td>55</td><td/></tr><tr><td>&#160;Colonic</td><td/><td>11</td><td/></tr><tr><td>&#160;Isolated upper</td><td/><td>1</td><td/></tr><tr><td colspan="4">Disease severity</td></tr><tr><td>&#160;Mild</td><td>51</td><td>17</td><td/></tr><tr><td>&#160;Moderate</td><td>38</td><td>45</td><td/></tr><tr><td>&#160;Severe</td><td>21</td><td>9</td><td/></tr><tr><td>&#160;Unknown</td><td>4</td><td>12</td><td/></tr><tr><td colspan="4">Disease activity</td></tr><tr><td>&#160;Active</td><td>63</td><td>54</td><td/></tr><tr><td>&#160;Inactive</td><td>48</td><td>17</td><td/></tr><tr><td>&#160;Unknown</td><td>3</td><td>12</td><td/></tr><tr><td colspan="4">Behavior of CD<sup>a</sup></td></tr><tr><td>&#160;Stricturing</td><td/><td>44</td><td/></tr><tr><td>&#160;Penetrating</td><td/><td>40</td><td/></tr><tr><td>&#160;Perianal diseases</td><td/><td>36</td><td/></tr></tbody></table><table-wrap-foot><p textid="19"><italic>SD</italic> standard deviation</p><p textid="20">*<italic>P</italic>&#8201;&lt;&#8201;0.01 in comparison to control subjects</p><p textid="21"><sup>a</sup>Number of the affected patients with CD</p></table-wrap-foot></table-wrap>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
###xml 115 123 <span type="species:ncbi:9606">patients</span>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
###xml 489 494 <span type="species:ncbi:9606">Human</span>
###xml 1308 1316 <span type="species:ncbi:9606">patients</span>
The study subjects were Japanese who were unrelated to one another. The subjects included 112 patients with UC, 83 patients with CD, and 200 gender-matched, healthy volunteers as control subjects. IBD patients were enrolled from eight general hospitals in Nagasaki, Japan from October 2003 to October 2008. The clinical characteristics of the subjects at the end point of this study are shown in Table I. The study protocol was approved by the Committee for Ethical Issue dealing with the Human Genome and Gene Analysis at Nagasaki University, and written informed consent was obtained from each subject. Table IThe Clinical Characteristics of Study SubjectsCharacteristicsPatients withControl subjectsUCCDNumber11483200Age, mean +/- SD (years)44.2 +/- 16.7*34.3 +/- 12.532.5 +/- 11.2Age range (years)14-8317-7520-60Male/female (%)59/55 (51.7/48.3)50/33 (60.2/39.8)126/74 (62.5/37.5)Age at onset </=40 years3911 >/=40 years7572Extent of UC Proctitis14 Left-sided colitis43 Pancolitis57Location of CD Ileal16 Ileocolonic55 Colonic11 Isolated upper1Disease severity Mild5117 Moderate3845 Severe219 Unknown412Disease activity Active6354 Inactive4817 Unknown312Behavior of CDa Stricturing44 Penetrating40 Perianal diseases36SD standard deviation*P < 0.01 in comparison to control subjectsaNumber of the affected patients with CD
###end p 17
###begin p 18
The Clinical Characteristics of Study Subjects
###end p 18
###begin p 19
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SD</italic>
SD standard deviation
###end p 19
###begin p 20
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
*P < 0.01 in comparison to control subjects
###end p 20
###begin p 21
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 24 32 <span type="species:ncbi:9606">patients</span>
aNumber of the affected patients with CD
###end p 21
###begin p 22
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 303 311 <span type="species:ncbi:9606">Patients</span>
The diagnosis of IBD was made based on the endoscopic, radiological, histological, and clinical criteria established by both the World Health Organization Council for International Organizations of Medical Sciences and the International Organization for the Study of Inflammatory Bowel Disease [23-25]. Patients with indeterminate colitis, multiple sclerosis, systemic lupus erythematosus, or any other diagnosed autoimmune diseases were excluded from this study.
###end p 22
###begin p 23
###xml 262 263 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">I</xref>
###xml 607 608 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">I</xref>
###xml 766 768 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 847 849 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 909 911 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
###xml 943 951 <span type="species:ncbi:9606">patients</span>
Patients with UC were classified into subgroups according to age at onset (</=40 or >/=40 years), extension of disease (proctitis, left-sided colitis, or pancolitis), disease severity (mild, moderate, or severe), and disease activity (active or inactive) (Table I). Likewise, patients with CD were classified into subgroups according to age at onset (</=40 or >/=40 years), the location of lesions (ileal, ileocolonic, colonic, or isolated upper), disease severity (mild, moderate, or severe), disease activity (active or inactive), and the behavior of disease (stricturing, penetrating, or perianal; Table I). The location and extension of UC and CD, disease severity of UC and CD, and behavior of CD were stratified in accordance with the Montreal classification [26] with slight modification. A high clinical activity index (CAI >/= 5) for UC [27] and a high Crohn's disease activity index (CDAI >/= 150) [28] were regarded as active-phase patients.
###end p 23
###begin title 24
Preparation of Genomic DNA
###end title 24
###begin p 25
Genomic DNA was extracted from a whole blood sample from each subject using a DNA Extractor WB-Rapid Kit (Wako, Osaka, Japan) according to the manufacturer's protocol.
###end p 25
###begin title 26
Sources of the Candidate Genes and Their Polymorphisms
###end title 26
###begin p 27
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 583 588 583 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 593 597 593 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 617 618 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 623 624 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 640 646 640 646 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 690 695 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 725 730 725 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper</italic>
###xml 742 747 742 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower</italic>
###xml 759 774 759 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">horizontal bars</italic>
###xml 822 827 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 829 847 829 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Blue vertical bars</italic>
###xml 889 906 889 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yellow rectangles</italic>
###xml 1029 1049 1029 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower right position</italic>
###xml 1080 1102 1080 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Red inverted triangles</italic>
###xml 1186 1214 1186 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above each inverted triangle</italic>
###xml 646 1214 646 1214 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">Locations of the genotyped tag SNP sites in <italic>STAT3</italic> in the International HapMap (<italic>upper</italic>) and iHap (<italic>lower</italic>) data. The <italic>horizontal bars</italic> in the middle indicate the genomic sequence of <italic>STAT3</italic>. <italic>Blue vertical bars</italic> indicate the positions of all SNP sites. <italic>Yellow rectangles</italic> represent the positions of linkage disequilibrium blocks. A list and the locations of candidate tag SNPs are shown in the <italic>lower right position</italic> using Haploview 4.0 software. <italic>Red inverted triangles</italic> indicate the genotyped tag SNPs sites in this study, and their names are presented <italic>above each inverted triangle</italic></p>
###xml 646 1214 646 1214 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">Locations of the genotyped tag SNP sites in <italic>STAT3</italic> in the International HapMap (<italic>upper</italic>) and iHap (<italic>lower</italic>) data. The <italic>horizontal bars</italic> in the middle indicate the genomic sequence of <italic>STAT3</italic>. <italic>Blue vertical bars</italic> indicate the positions of all SNP sites. <italic>Yellow rectangles</italic> represent the positions of linkage disequilibrium blocks. A list and the locations of candidate tag SNPs are shown in the <italic>lower right position</italic> using Haploview 4.0 software. <italic>Red inverted triangles</italic> indicate the genotyped tag SNPs sites in this study, and their names are presented <italic>above each inverted triangle</italic></p></caption>
###xml 1214 1214 1214 1214 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10875_2009_9320_Fig1_HTML" id="MO1"/>
###xml 640 1214 640 1214 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="28">Locations of the genotyped tag SNP sites in <italic>STAT3</italic> in the International HapMap (<italic>upper</italic>) and iHap (<italic>lower</italic>) data. The <italic>horizontal bars</italic> in the middle indicate the genomic sequence of <italic>STAT3</italic>. <italic>Blue vertical bars</italic> indicate the positions of all SNP sites. <italic>Yellow rectangles</italic> represent the positions of linkage disequilibrium blocks. A list and the locations of candidate tag SNPs are shown in the <italic>lower right position</italic> using Haploview 4.0 software. <italic>Red inverted triangles</italic> indicate the genotyped tag SNPs sites in this study, and their names are presented <italic>above each inverted triangle</italic></p></caption><graphic position="anchor" xlink:href="10875_2009_9320_Fig1_HTML" id="MO1"/></fig>
###xml 1214 1220 1214 1220 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1264 1268 1264 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 1298 1303 1298 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper</italic>
###xml 1315 1320 1315 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower</italic>
###xml 1332 1361 1332 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">horizontal bars in the middle</italic>
###xml 1395 1399 1395 1399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 1401 1419 1401 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Blue vertical bars</italic>
###xml 1463 1479 1463 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yellow rectangle</italic>
###xml 1604 1624 1604 1624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower right position</italic>
###xml 1655 1677 1655 1677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Red inverted triangles</italic>
###xml 1761 1789 1761 1789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above each inverted triangle</italic>
###xml 1220 1789 1220 1789 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29">Locations of the genotyped tag SNP sites in <italic>TYK2</italic> in the International HapMap (<italic>upper</italic>) and iHap (<italic>lower</italic>) data. The <italic>horizontal bars in the middle</italic> indicate the genomic sequence of <italic>TYK2</italic>. <italic>Blue vertical bars</italic> indicate the positions of all SNP sites. A <italic>yellow rectangle</italic> represents the positions of a linkage disequilibrium block. A list and the locations of candidate tag SNPs are shown in the <italic>lower right position</italic> using Haploview 4.0 software. <italic>Red inverted triangles</italic> indicate the genotyped tag SNPs sites in this study, and their names are presented <italic>above each inverted triangle</italic></p>
###xml 1220 1789 1220 1789 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29">Locations of the genotyped tag SNP sites in <italic>TYK2</italic> in the International HapMap (<italic>upper</italic>) and iHap (<italic>lower</italic>) data. The <italic>horizontal bars in the middle</italic> indicate the genomic sequence of <italic>TYK2</italic>. <italic>Blue vertical bars</italic> indicate the positions of all SNP sites. A <italic>yellow rectangle</italic> represents the positions of a linkage disequilibrium block. A list and the locations of candidate tag SNPs are shown in the <italic>lower right position</italic> using Haploview 4.0 software. <italic>Red inverted triangles</italic> indicate the genotyped tag SNPs sites in this study, and their names are presented <italic>above each inverted triangle</italic></p></caption>
###xml 1789 1789 1789 1789 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10875_2009_9320_Fig2_HTML" id="MO2"/>
###xml 1214 1789 1214 1789 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="29">Locations of the genotyped tag SNP sites in <italic>TYK2</italic> in the International HapMap (<italic>upper</italic>) and iHap (<italic>lower</italic>) data. The <italic>horizontal bars in the middle</italic> indicate the genomic sequence of <italic>TYK2</italic>. <italic>Blue vertical bars</italic> indicate the positions of all SNP sites. A <italic>yellow rectangle</italic> represents the positions of a linkage disequilibrium block. A list and the locations of candidate tag SNPs are shown in the <italic>lower right position</italic> using Haploview 4.0 software. <italic>Red inverted triangles</italic> indicate the genotyped tag SNPs sites in this study, and their names are presented <italic>above each inverted triangle</italic></p></caption><graphic position="anchor" xlink:href="10875_2009_9320_Fig2_HTML" id="MO2"/></fig>
All of SNPs in STAT3 (GenBank accession number, AY572796; MIM 102582) located on chromosome 17q21 [29] and TYK2 (GenBank accession number, AY549314; MIM 176941) located on chromosome 19p13.2 [30] were obtained using data available on the International HapMap Web site [31]. Candidate tag SNPs were selected with priority in a minor allele frequency of more than 5%. Subsequently, linkage disequilibrium blocks and genotyped tag SNPs among the candidate tag SNPs were determined using the iHAP software program [32]. The gene structure and positions of the genotyped tag SNP sites in STAT3 and TYK2 are shown in Figs. 1 and 2, respectively. Fig. 1Locations of the genotyped tag SNP sites in STAT3 in the International HapMap (upper) and iHap (lower) data. The horizontal bars in the middle indicate the genomic sequence of STAT3. Blue vertical bars indicate the positions of all SNP sites. Yellow rectangles represent the positions of linkage disequilibrium blocks. A list and the locations of candidate tag SNPs are shown in the lower right position using Haploview 4.0 software. Red inverted triangles indicate the genotyped tag SNPs sites in this study, and their names are presented above each inverted triangleFig. 2Locations of the genotyped tag SNP sites in TYK2 in the International HapMap (upper) and iHap (lower) data. The horizontal bars in the middle indicate the genomic sequence of TYK2. Blue vertical bars indicate the positions of all SNP sites. A yellow rectangle represents the positions of a linkage disequilibrium block. A list and the locations of candidate tag SNPs are shown in the lower right position using Haploview 4.0 software. Red inverted triangles indicate the genotyped tag SNPs sites in this study, and their names are presented above each inverted triangle
###end p 27
###begin p 28
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper</italic>
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower</italic>
###xml 113 128 113 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">horizontal bars</italic>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 183 201 183 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Blue vertical bars</italic>
###xml 243 260 243 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yellow rectangles</italic>
###xml 383 403 383 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower right position</italic>
###xml 434 456 434 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Red inverted triangles</italic>
###xml 540 568 540 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above each inverted triangle</italic>
Locations of the genotyped tag SNP sites in STAT3 in the International HapMap (upper) and iHap (lower) data. The horizontal bars in the middle indicate the genomic sequence of STAT3. Blue vertical bars indicate the positions of all SNP sites. Yellow rectangles represent the positions of linkage disequilibrium blocks. A list and the locations of candidate tag SNPs are shown in the lower right position using Haploview 4.0 software. Red inverted triangles indicate the genotyped tag SNPs sites in this study, and their names are presented above each inverted triangle
###end p 28
###begin p 29
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper</italic>
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower</italic>
###xml 112 141 112 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">horizontal bars in the middle</italic>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 181 199 181 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Blue vertical bars</italic>
###xml 243 259 243 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yellow rectangle</italic>
###xml 384 404 384 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower right position</italic>
###xml 435 457 435 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Red inverted triangles</italic>
###xml 541 569 541 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">above each inverted triangle</italic>
Locations of the genotyped tag SNP sites in TYK2 in the International HapMap (upper) and iHap (lower) data. The horizontal bars in the middle indicate the genomic sequence of TYK2. Blue vertical bars indicate the positions of all SNP sites. A yellow rectangle represents the positions of a linkage disequilibrium block. A list and the locations of candidate tag SNPs are shown in the lower right position using Haploview 4.0 software. Red inverted triangles indicate the genotyped tag SNPs sites in this study, and their names are presented above each inverted triangle
###end p 29
###begin title 30
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
Determination of Three SNPs in STAT3
###end title 30
###begin p 31
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1177 1180 1143 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hpa</italic>
###xml 1245 1248 1211 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xsp</italic>
Three SNPs, rs8074524 in intron 3, rs2293152 in intron 11, and rs957970 in intron 23, were selected as genotyped tag SNPs (Fig. 1) and were subsequently analyzed by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP). The polymorphic region was amplified by PCR with a GeneAmp PCR System 9700 thermal cycler (Applied Biosystems, Foster City, CA, USA) using 25 ng of genomic DNA in a 25-microl reaction mixture containing 0.8x GoTaq Green master mix (Promega, Madison, WI, USA) and 15 pmol each of the following primers: forward primer 5'-GTCTGGAAAGCTCCATCTGC-3' and reverse primer 5'-AGAGGCCAGATTAGTGCTGG-3' for rs8074524; forward primer 5'-TCCCCTGTGATTCAGATCCC-3' and reverse primer 5'-CATTCCCACATCTCTGCTCC-3' for rs2293152; and forward primer 5'-CTGGGCTCAAGTGATCTTCC-3' and reverse primer 5'-GTACTCATCGCCCTCCATTG-3' for rs957970. The amplification protocol comprised initial denaturation at 95degreesC for 2 min, followed by 30 cycles of denaturation at 95degreesC for 30 s, annealing at 62degreesC for 30 s, and extension at 72degreesC for 30 s and final extension at 72degreesC for 5 min. The PCR products were digested with restriction enzyme, Hpa II (Takara Bio Inc., Kyoto, Japan) for rs8074524 and rs2293152; Xsp I (Takara Bio Inc.) for rs957970. The digests were separated by electrophoresis on a 2% agarose gel (Nacalai Tesque, Kyoto, Japan) and visualized with an ultraviolet transilluminator (Alpha Innotech Co., San Leandro, CA, USA) after ethidium bromide (Nacalai Tesque) staining.
###end p 31
###begin title 32
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
Determination of Four SNPs in TYK2
###end title 32
###begin p 33
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1056 1059 1020 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsl</italic>
###xml 1121 1124 1085 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hpy</italic>
###xml 1170 1173 1134 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 1222 1225 1186 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsi</italic>
Four genotyped tag SNPs in TYK2, rs280496 in intron 3, rs280519 in intron 14, rs2304256 in intron 18, and rs280523 in intron 20 (Fig. 2), were analyzed by PCR-RFLP using 15 pmol each of the following primers: forward primer 5'-CGGGGTGATATGCTCATTGG-3' and reverse primer 5'-CAACGTGCTGCTGGACAACG-3' for rs280496; forward primer 5'-CCGCCATGGTGAAAGTTAGC-3' and reverse primer 5'-ATTTGTGCAGGCCAAGCTGC-3' for rs280519; forward primer 5'-TCACCAGGCACTTGTTGTCC-3' and reverse primer 5'-CGGCTTCCAGCATGTGTATG-3' for rs2304256; and forward primer 5'-ACATTTCCCCCTGCCTACAC-3' and reverse primer 5'-TTACAGACATGCGCCACCAC-3' for rs280523. The other constituents of the PCR mixture were the same as described above. The amplification protocol comprised initial denaturation at 95degreesC for 2 min, followed by 30 cycles of denaturation at 95degreesC for 30 s, annealing at 64degreesC (rs280496, rs280519, and rs280523) or 62degreesC (rs2304256) for 30 s, and extension at 72degreesC for 30 s and final extension at 72degreesC for 5 min. The PCR products were digested with Bsl I (New England BioLabs Inc., Beverly, MA, USA) for rs280496, Hpy99 I (New England BioLabs Inc.) for rs280519, Bsm I (New England BioLabs Inc.) for rs2304256, and BsiE I (New England BioLabs Inc.) for rs280523. The digests were then separated on a 2% agarose gel as described above.
###end p 33
###begin title 34
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
Haplotype Structure of TYK2
###end title 34
###begin p 35
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
Two tag SNPs in TYK2, which showed a close association of susceptibility to CD and were located within the same linkage disequilibrium block (Fig. 2), were utilized to infer the haplotype structure as well as to analyze the haplotype frequency using the SNP Alyze 7.0 standard software package (Dynacom Inc., Yokohama, Japan) to emphasize the variability and to enhance the power of detecting allelic association of rare variants [33, 34].
###end p 35
###begin title 36
Statistical Analysis
###end title 36
###begin p 37
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 948 953 948 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 971 975 971 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 1165 1166 1165 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
###xml 730 738 <span type="species:ncbi:9606">patients</span>
Differences in age and gender between UC or CD patients and control subjects were evaluated by an unpaired Student's t test and a chi-square test, respectively, using the SPSS 17 (SPSS Japan Inc., Tokyo, Japan) and Prism 5 (GraphPad Software Inc., San Diego, CA, USA) statistical software packages. The frequencies of the expected alleles were calculated from those of the observed genotypes according to the Hardy-Weinberg equilibrium. The frequencies of the observed and expected alleles were compared by the chi-square test with Yates' correction using the SNP Alyze 7.0 standard software package. The frequencies and distributions of alleles, genotypes, haplotypes, and diplotypes were statistically compared between UC or CD patients and control subjects by the chi-square test and logistic regression analysis using Prism 5 and SPSS 17. Subsequently, a comparison of the genetic risk factors between the statistically significant genotype of STAT3 and diplotype of TYK2 for susceptibility to CD was carried out by a multivariate logistic regression analysis using SPSS 17. The odds ratio (OR) with 95% confidence interval (CI) was calculated using SPSS 17. A P value of less than 0.05 was considered to be statistically significant.
###end p 37
###begin title 38
Results
###end title 38
###begin title 39
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
Association of Tag SNPs in STAT3 with Susceptibility to IBD
###end title 39
###begin p 40
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">II</xref>
###xml 181 184 181 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">III</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">II</xref>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 575 583 575 583 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table II</label>
###xml 654 659 654 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 664 668 664 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 583 689 583 689 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="41">Distributions of Polymorphic Alleles at the Genotyped Tag SNP Sites in <italic>STAT3</italic> and <italic>TYK2</italic> Among Study Subjects</p>
###xml 583 689 583 689 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="41">Distributions of Polymorphic Alleles at the Genotyped Tag SNP Sites in <italic>STAT3</italic> and <italic>TYK2</italic> Among Study Subjects</p></caption>
###xml 689 693 689 693 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Gene</th>
###xml 693 696 693 696 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">SNP</th>
###xml 696 702 696 702 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Allele</th>
###xml 702 726 702 726 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Number (%) of alleles in</th>
###xml 743 744 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 726 744 726 744 <th xmlns:xlink="http://www.w3.org/1999/xlink">Allele comparison<sup>a</sup></th>
###xml 744 768 744 768 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Number (%) of alleles in</th>
###xml 785 786 785 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 768 786 768 786 <th xmlns:xlink="http://www.w3.org/1999/xlink">Allele comparison<sup>a</sup></th>
###xml 689 786 689 786 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">Gene</th><th rowspan="2">SNP</th><th rowspan="2">Allele</th><th colspan="2">Number (%) of alleles in</th><th>Allele comparison<sup>a</sup></th><th colspan="2">Number (%) of alleles in</th><th>Allele comparison<sup>a</sup></th></tr>
###xml 786 788 786 788 <th xmlns:xlink="http://www.w3.org/1999/xlink">UC</th>
###xml 788 795 788 795 <th xmlns:xlink="http://www.w3.org/1999/xlink">Control</th>
###xml 795 796 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 795 802 795 802 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>P</italic> value</th>
###xml 802 804 802 804 <th xmlns:xlink="http://www.w3.org/1999/xlink">CD</th>
###xml 804 811 804 811 <th xmlns:xlink="http://www.w3.org/1999/xlink">Control</th>
###xml 811 812 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 811 818 811 818 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>P</italic> value</th>
###xml 786 818 786 818 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>UC</th><th>Control</th><th><italic>P</italic> value</th><th>CD</th><th>Control</th><th><italic>P</italic> value</th></tr>
###xml 689 818 689 818 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">Gene</th><th rowspan="2">SNP</th><th rowspan="2">Allele</th><th colspan="2">Number (%) of alleles in</th><th>Allele comparison<sup>a</sup></th><th colspan="2">Number (%) of alleles in</th><th>Allele comparison<sup>a</sup></th></tr><tr><th>UC</th><th>Control</th><th><italic>P</italic> value</th><th>CD</th><th>Control</th><th><italic>P</italic> value</th></tr></thead>
###xml 818 823 818 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 818 823 818 823 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="6"><italic>STAT3</italic></td>
###xml 823 832 823 832 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">rs8074524</td>
###xml 832 833 832 833 <td xmlns:xlink="http://www.w3.org/1999/xlink">C</td>
###xml 833 843 833 843 <td xmlns:xlink="http://www.w3.org/1999/xlink">144 (64.3)</td>
###xml 843 853 843 853 <td xmlns:xlink="http://www.w3.org/1999/xlink">253 (63.3)</td>
###xml 853 858 853 858 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char" rowspan="2">0.759</td>
###xml 858 868 858 868 <td xmlns:xlink="http://www.w3.org/1999/xlink">106 (63.9)</td>
###xml 868 878 868 878 <td xmlns:xlink="http://www.w3.org/1999/xlink">253 (63.3)</td>
###xml 878 883 878 883 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.892</td>
###xml 818 883 818 883 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="6"><italic>STAT3</italic></td><td rowspan="2">rs8074524</td><td>C</td><td>144 (64.3)</td><td>253 (63.3)</td><td char="." align="char" rowspan="2">0.759</td><td>106 (63.9)</td><td>253 (63.3)</td><td char="." align="char">0.892</td></tr>
###xml 883 884 883 884 <td xmlns:xlink="http://www.w3.org/1999/xlink">T</td>
###xml 884 893 884 893 <td xmlns:xlink="http://www.w3.org/1999/xlink">80 (35.7)</td>
###xml 893 903 893 903 <td xmlns:xlink="http://www.w3.org/1999/xlink">147 (36.7)</td>
###xml 903 912 903 912 <td xmlns:xlink="http://www.w3.org/1999/xlink">60 (36.1)</td>
###xml 912 922 912 922 <td xmlns:xlink="http://www.w3.org/1999/xlink">147 (36.7)</td>
###xml 922 922 922 922 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 883 922 883 922 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>T</td><td>80 (35.7)</td><td>147 (36.7)</td><td>60 (36.1)</td><td>147 (36.7)</td><td/></tr>
###xml 922 931 922 931 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">rs2293152</td>
###xml 931 932 931 932 <td xmlns:xlink="http://www.w3.org/1999/xlink">G</td>
###xml 932 942 932 942 <td xmlns:xlink="http://www.w3.org/1999/xlink">151 (66.2)</td>
###xml 942 952 942 952 <td xmlns:xlink="http://www.w3.org/1999/xlink">267 (66.7)</td>
###xml 952 957 952 957 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char" rowspan="2">0.894</td>
###xml 957 966 957 966 <td xmlns:xlink="http://www.w3.org/1999/xlink">91 (54.8)</td>
###xml 966 976 966 976 <td xmlns:xlink="http://www.w3.org/1999/xlink">267 (66.7)</td>
###xml 976 981 976 981 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.007</td>
###xml 922 981 922 981 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="2">rs2293152</td><td>G</td><td>151 (66.2)</td><td>267 (66.7)</td><td char="." align="char" rowspan="2">0.894</td><td>91 (54.8)</td><td>267 (66.7)</td><td char="." align="char">0.007</td></tr>
###xml 981 982 981 982 <td xmlns:xlink="http://www.w3.org/1999/xlink">C</td>
###xml 982 991 982 991 <td xmlns:xlink="http://www.w3.org/1999/xlink">77 (33.8)</td>
###xml 991 1001 991 1001 <td xmlns:xlink="http://www.w3.org/1999/xlink">133 (33.3)</td>
###xml 1001 1010 1001 1010 <td xmlns:xlink="http://www.w3.org/1999/xlink">75 (45.2)</td>
###xml 1010 1020 1010 1020 <td xmlns:xlink="http://www.w3.org/1999/xlink">133 (33.3)</td>
###xml 1020 1020 1020 1020 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 981 1020 981 1020 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>C</td><td>77 (33.8)</td><td>133 (33.3)</td><td>75 (45.2)</td><td>133 (33.3)</td><td/></tr>
###xml 1020 1028 1020 1028 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">rs957970</td>
###xml 1028 1029 1028 1029 <td xmlns:xlink="http://www.w3.org/1999/xlink">A</td>
###xml 1029 1039 1029 1039 <td xmlns:xlink="http://www.w3.org/1999/xlink">116 (51.8)</td>
###xml 1039 1049 1039 1049 <td xmlns:xlink="http://www.w3.org/1999/xlink">218 (54.5)</td>
###xml 1049 1054 1049 1054 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char" rowspan="2">0.652</td>
###xml 1054 1063 1054 1063 <td xmlns:xlink="http://www.w3.org/1999/xlink">84 (50.6)</td>
###xml 1063 1073 1063 1073 <td xmlns:xlink="http://www.w3.org/1999/xlink">218 (54.5)</td>
###xml 1073 1078 1073 1078 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.397</td>
###xml 1020 1078 1020 1078 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="2">rs957970</td><td>A</td><td>116 (51.8)</td><td>218 (54.5)</td><td char="." align="char" rowspan="2">0.652</td><td>84 (50.6)</td><td>218 (54.5)</td><td char="." align="char">0.397</td></tr>
###xml 1078 1079 1078 1079 <td xmlns:xlink="http://www.w3.org/1999/xlink">G</td>
###xml 1079 1089 1079 1089 <td xmlns:xlink="http://www.w3.org/1999/xlink">108 (48.2)</td>
###xml 1089 1099 1089 1099 <td xmlns:xlink="http://www.w3.org/1999/xlink">182 (45.5)</td>
###xml 1099 1108 1099 1108 <td xmlns:xlink="http://www.w3.org/1999/xlink">82 (49.4)</td>
###xml 1108 1118 1108 1118 <td xmlns:xlink="http://www.w3.org/1999/xlink">182 (45.5)</td>
###xml 1118 1118 1118 1118 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1078 1118 1078 1118 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>G</td><td>108 (48.2)</td><td>182 (45.5)</td><td>82 (49.4)</td><td>182 (45.5)</td><td/></tr>
###xml 1118 1122 1118 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 1118 1122 1118 1122 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="8"><italic>TYK2</italic></td>
###xml 1122 1130 1122 1130 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">rs280496</td>
###xml 1130 1131 1130 1131 <td xmlns:xlink="http://www.w3.org/1999/xlink">C</td>
###xml 1131 1141 1131 1141 <td xmlns:xlink="http://www.w3.org/1999/xlink">201 (89.7)</td>
###xml 1141 1151 1141 1151 <td xmlns:xlink="http://www.w3.org/1999/xlink">362 (90.5)</td>
###xml 1151 1156 1151 1156 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char" rowspan="2">0.784</td>
###xml 1156 1166 1156 1166 <td xmlns:xlink="http://www.w3.org/1999/xlink">144 (86.7)</td>
###xml 1166 1176 1166 1176 <td xmlns:xlink="http://www.w3.org/1999/xlink">362 (90.5)</td>
###xml 1176 1181 1176 1181 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.187</td>
###xml 1118 1181 1118 1181 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="8"><italic>TYK2</italic></td><td rowspan="2">rs280496</td><td>C</td><td>201 (89.7)</td><td>362 (90.5)</td><td char="." align="char" rowspan="2">0.784</td><td>144 (86.7)</td><td>362 (90.5)</td><td char="." align="char">0.187</td></tr>
###xml 1181 1182 1181 1182 <td xmlns:xlink="http://www.w3.org/1999/xlink">G</td>
###xml 1182 1191 1182 1191 <td xmlns:xlink="http://www.w3.org/1999/xlink">23 (10.3)</td>
###xml 1191 1199 1191 1199 <td xmlns:xlink="http://www.w3.org/1999/xlink">38 (9.5)</td>
###xml 1199 1208 1199 1208 <td xmlns:xlink="http://www.w3.org/1999/xlink">22 (13.3)</td>
###xml 1208 1216 1208 1216 <td xmlns:xlink="http://www.w3.org/1999/xlink">38 (9.5)</td>
###xml 1216 1216 1216 1216 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1181 1216 1181 1216 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>G</td><td>23 (10.3)</td><td>38 (9.5)</td><td>22 (13.3)</td><td>38 (9.5)</td><td/></tr>
###xml 1216 1224 1216 1224 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">rs280519</td>
###xml 1224 1225 1224 1225 <td xmlns:xlink="http://www.w3.org/1999/xlink">A</td>
###xml 1225 1235 1225 1235 <td xmlns:xlink="http://www.w3.org/1999/xlink">136 (60.7)</td>
###xml 1235 1245 1235 1245 <td xmlns:xlink="http://www.w3.org/1999/xlink">224 (56.0)</td>
###xml 1245 1250 1245 1250 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char" rowspan="2">0.261</td>
###xml 1250 1260 1250 1260 <td xmlns:xlink="http://www.w3.org/1999/xlink">109 (65.7)</td>
###xml 1260 1270 1260 1270 <td xmlns:xlink="http://www.w3.org/1999/xlink">224 (56.0)</td>
###xml 1270 1275 1270 1275 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.034</td>
###xml 1216 1275 1216 1275 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="2">rs280519</td><td>A</td><td>136 (60.7)</td><td>224 (56.0)</td><td char="." align="char" rowspan="2">0.261</td><td>109 (65.7)</td><td>224 (56.0)</td><td char="." align="char">0.034</td></tr>
###xml 1275 1276 1275 1276 <td xmlns:xlink="http://www.w3.org/1999/xlink">G</td>
###xml 1276 1285 1276 1285 <td xmlns:xlink="http://www.w3.org/1999/xlink">88 (39.3)</td>
###xml 1285 1295 1285 1295 <td xmlns:xlink="http://www.w3.org/1999/xlink">176 (44.0)</td>
###xml 1295 1304 1295 1304 <td xmlns:xlink="http://www.w3.org/1999/xlink">57 (34.3)</td>
###xml 1304 1314 1304 1314 <td xmlns:xlink="http://www.w3.org/1999/xlink">176 (44.0)</td>
###xml 1314 1314 1314 1314 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1275 1314 1275 1314 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>G</td><td>88 (39.3)</td><td>176 (44.0)</td><td>57 (34.3)</td><td>176 (44.0)</td><td/></tr>
###xml 1314 1323 1314 1323 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">rs2304256</td>
###xml 1323 1324 1323 1324 <td xmlns:xlink="http://www.w3.org/1999/xlink">C</td>
###xml 1324 1334 1324 1334 <td xmlns:xlink="http://www.w3.org/1999/xlink">156 (69.6)</td>
###xml 1334 1344 1334 1344 <td xmlns:xlink="http://www.w3.org/1999/xlink">262 (65.5)</td>
###xml 1344 1349 1344 1349 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char" rowspan="2">0.311</td>
###xml 1349 1359 1349 1359 <td xmlns:xlink="http://www.w3.org/1999/xlink">129 (77.7)</td>
###xml 1359 1369 1359 1369 <td xmlns:xlink="http://www.w3.org/1999/xlink">262 (65.5)</td>
###xml 1369 1374 1369 1374 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.004</td>
###xml 1314 1374 1314 1374 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="2">rs2304256</td><td>C</td><td>156 (69.6)</td><td>262 (65.5)</td><td char="." align="char" rowspan="2">0.311</td><td>129 (77.7)</td><td>262 (65.5)</td><td char="." align="char">0.004</td></tr>
###xml 1374 1375 1374 1375 <td xmlns:xlink="http://www.w3.org/1999/xlink">A</td>
###xml 1375 1384 1375 1384 <td xmlns:xlink="http://www.w3.org/1999/xlink">68 (30.4)</td>
###xml 1384 1394 1384 1394 <td xmlns:xlink="http://www.w3.org/1999/xlink">138 (34.5)</td>
###xml 1394 1403 1394 1403 <td xmlns:xlink="http://www.w3.org/1999/xlink">37 (23.3)</td>
###xml 1403 1413 1403 1413 <td xmlns:xlink="http://www.w3.org/1999/xlink">138 (34.5)</td>
###xml 1413 1413 1413 1413 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1374 1413 1374 1413 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>A</td><td>68 (30.4)</td><td>138 (34.5)</td><td>37 (23.3)</td><td>138 (34.5)</td><td/></tr>
###xml 1413 1421 1413 1421 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">rs280523</td>
###xml 1421 1422 1421 1422 <td xmlns:xlink="http://www.w3.org/1999/xlink">G</td>
###xml 1422 1432 1422 1432 <td xmlns:xlink="http://www.w3.org/1999/xlink">207 (92.4)</td>
###xml 1432 1442 1432 1442 <td xmlns:xlink="http://www.w3.org/1999/xlink">370 (92.5)</td>
###xml 1442 1447 1442 1447 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char" rowspan="2">0.968</td>
###xml 1447 1457 1447 1457 <td xmlns:xlink="http://www.w3.org/1999/xlink">154 (92.8)</td>
###xml 1457 1467 1457 1467 <td xmlns:xlink="http://www.w3.org/1999/xlink">370 (92.5)</td>
###xml 1467 1472 1467 1472 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.911</td>
###xml 1413 1472 1413 1472 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="2">rs280523</td><td>G</td><td>207 (92.4)</td><td>370 (92.5)</td><td char="." align="char" rowspan="2">0.968</td><td>154 (92.8)</td><td>370 (92.5)</td><td char="." align="char">0.911</td></tr>
###xml 1472 1473 1472 1473 <td xmlns:xlink="http://www.w3.org/1999/xlink">A</td>
###xml 1473 1481 1473 1481 <td xmlns:xlink="http://www.w3.org/1999/xlink">17 (7.6)</td>
###xml 1481 1489 1481 1489 <td xmlns:xlink="http://www.w3.org/1999/xlink">30 (7.5)</td>
###xml 1489 1497 1489 1497 <td xmlns:xlink="http://www.w3.org/1999/xlink">12 (7.2)</td>
###xml 1497 1505 1497 1505 <td xmlns:xlink="http://www.w3.org/1999/xlink">30 (7.5)</td>
###xml 1505 1505 1505 1505 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1472 1505 1472 1505 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>A</td><td>17 (7.6)</td><td>30 (7.5)</td><td>12 (7.2)</td><td>30 (7.5)</td><td/></tr>
###xml 1505 1528 1505 1528 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">Total number of alleles</td>
###xml 1528 1531 1528 1531 <td xmlns:xlink="http://www.w3.org/1999/xlink">228</td>
###xml 1531 1534 1531 1534 <td xmlns:xlink="http://www.w3.org/1999/xlink">400</td>
###xml 1534 1534 1534 1534 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1534 1537 1534 1537 <td xmlns:xlink="http://www.w3.org/1999/xlink">166</td>
###xml 1537 1540 1537 1540 <td xmlns:xlink="http://www.w3.org/1999/xlink">400</td>
###xml 1540 1540 1540 1540 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1505 1540 1505 1540 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="3">Total number of alleles</td><td>228</td><td>400</td><td/><td>166</td><td>400</td><td/></tr>
###xml 818 1540 818 1540 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td rowspan="6"><italic>STAT3</italic></td><td rowspan="2">rs8074524</td><td>C</td><td>144 (64.3)</td><td>253 (63.3)</td><td char="." align="char" rowspan="2">0.759</td><td>106 (63.9)</td><td>253 (63.3)</td><td char="." align="char">0.892</td></tr><tr><td>T</td><td>80 (35.7)</td><td>147 (36.7)</td><td>60 (36.1)</td><td>147 (36.7)</td><td/></tr><tr><td rowspan="2">rs2293152</td><td>G</td><td>151 (66.2)</td><td>267 (66.7)</td><td char="." align="char" rowspan="2">0.894</td><td>91 (54.8)</td><td>267 (66.7)</td><td char="." align="char">0.007</td></tr><tr><td>C</td><td>77 (33.8)</td><td>133 (33.3)</td><td>75 (45.2)</td><td>133 (33.3)</td><td/></tr><tr><td rowspan="2">rs957970</td><td>A</td><td>116 (51.8)</td><td>218 (54.5)</td><td char="." align="char" rowspan="2">0.652</td><td>84 (50.6)</td><td>218 (54.5)</td><td char="." align="char">0.397</td></tr><tr><td>G</td><td>108 (48.2)</td><td>182 (45.5)</td><td>82 (49.4)</td><td>182 (45.5)</td><td/></tr><tr><td rowspan="8"><italic>TYK2</italic></td><td rowspan="2">rs280496</td><td>C</td><td>201 (89.7)</td><td>362 (90.5)</td><td char="." align="char" rowspan="2">0.784</td><td>144 (86.7)</td><td>362 (90.5)</td><td char="." align="char">0.187</td></tr><tr><td>G</td><td>23 (10.3)</td><td>38 (9.5)</td><td>22 (13.3)</td><td>38 (9.5)</td><td/></tr><tr><td rowspan="2">rs280519</td><td>A</td><td>136 (60.7)</td><td>224 (56.0)</td><td char="." align="char" rowspan="2">0.261</td><td>109 (65.7)</td><td>224 (56.0)</td><td char="." align="char">0.034</td></tr><tr><td>G</td><td>88 (39.3)</td><td>176 (44.0)</td><td>57 (34.3)</td><td>176 (44.0)</td><td/></tr><tr><td rowspan="2">rs2304256</td><td>C</td><td>156 (69.6)</td><td>262 (65.5)</td><td char="." align="char" rowspan="2">0.311</td><td>129 (77.7)</td><td>262 (65.5)</td><td char="." align="char">0.004</td></tr><tr><td>A</td><td>68 (30.4)</td><td>138 (34.5)</td><td>37 (23.3)</td><td>138 (34.5)</td><td/></tr><tr><td rowspan="2">rs280523</td><td>G</td><td>207 (92.4)</td><td>370 (92.5)</td><td char="." align="char" rowspan="2">0.968</td><td>154 (92.8)</td><td>370 (92.5)</td><td char="." align="char">0.911</td></tr><tr><td>A</td><td>17 (7.6)</td><td>30 (7.5)</td><td>12 (7.2)</td><td>30 (7.5)</td><td/></tr><tr><td colspan="3">Total number of alleles</td><td>228</td><td>400</td><td/><td>166</td><td>400</td><td/></tr></tbody>
###xml 689 1540 689 1540 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">Gene</th><th rowspan="2">SNP</th><th rowspan="2">Allele</th><th colspan="2">Number (%) of alleles in</th><th>Allele comparison<sup>a</sup></th><th colspan="2">Number (%) of alleles in</th><th>Allele comparison<sup>a</sup></th></tr><tr><th>UC</th><th>Control</th><th><italic>P</italic> value</th><th>CD</th><th>Control</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td rowspan="6"><italic>STAT3</italic></td><td rowspan="2">rs8074524</td><td>C</td><td>144 (64.3)</td><td>253 (63.3)</td><td char="." align="char" rowspan="2">0.759</td><td>106 (63.9)</td><td>253 (63.3)</td><td char="." align="char">0.892</td></tr><tr><td>T</td><td>80 (35.7)</td><td>147 (36.7)</td><td>60 (36.1)</td><td>147 (36.7)</td><td/></tr><tr><td rowspan="2">rs2293152</td><td>G</td><td>151 (66.2)</td><td>267 (66.7)</td><td char="." align="char" rowspan="2">0.894</td><td>91 (54.8)</td><td>267 (66.7)</td><td char="." align="char">0.007</td></tr><tr><td>C</td><td>77 (33.8)</td><td>133 (33.3)</td><td>75 (45.2)</td><td>133 (33.3)</td><td/></tr><tr><td rowspan="2">rs957970</td><td>A</td><td>116 (51.8)</td><td>218 (54.5)</td><td char="." align="char" rowspan="2">0.652</td><td>84 (50.6)</td><td>218 (54.5)</td><td char="." align="char">0.397</td></tr><tr><td>G</td><td>108 (48.2)</td><td>182 (45.5)</td><td>82 (49.4)</td><td>182 (45.5)</td><td/></tr><tr><td rowspan="8"><italic>TYK2</italic></td><td rowspan="2">rs280496</td><td>C</td><td>201 (89.7)</td><td>362 (90.5)</td><td char="." align="char" rowspan="2">0.784</td><td>144 (86.7)</td><td>362 (90.5)</td><td char="." align="char">0.187</td></tr><tr><td>G</td><td>23 (10.3)</td><td>38 (9.5)</td><td>22 (13.3)</td><td>38 (9.5)</td><td/></tr><tr><td rowspan="2">rs280519</td><td>A</td><td>136 (60.7)</td><td>224 (56.0)</td><td char="." align="char" rowspan="2">0.261</td><td>109 (65.7)</td><td>224 (56.0)</td><td char="." align="char">0.034</td></tr><tr><td>G</td><td>88 (39.3)</td><td>176 (44.0)</td><td>57 (34.3)</td><td>176 (44.0)</td><td/></tr><tr><td rowspan="2">rs2304256</td><td>C</td><td>156 (69.6)</td><td>262 (65.5)</td><td char="." align="char" rowspan="2">0.311</td><td>129 (77.7)</td><td>262 (65.5)</td><td char="." align="char">0.004</td></tr><tr><td>A</td><td>68 (30.4)</td><td>138 (34.5)</td><td>37 (23.3)</td><td>138 (34.5)</td><td/></tr><tr><td rowspan="2">rs280523</td><td>G</td><td>207 (92.4)</td><td>370 (92.5)</td><td char="." align="char" rowspan="2">0.968</td><td>154 (92.8)</td><td>370 (92.5)</td><td char="." align="char">0.911</td></tr><tr><td>A</td><td>17 (7.6)</td><td>30 (7.5)</td><td>12 (7.2)</td><td>30 (7.5)</td><td/></tr><tr><td colspan="3">Total number of alleles</td><td>228</td><td>400</td><td/><td>166</td><td>400</td><td/></tr></tbody></table>
###xml 1540 1541 1540 1541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1540 1608 1540 1608 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42"><sup>a</sup>Each allele was compared to another allele using a chi-square test.</p>
###xml 1540 1608 1540 1608 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42"><sup>a</sup>Each allele was compared to another allele using a chi-square test.</p></table-wrap-foot>
###xml 575 1608 575 1608 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table II</label><caption><p textid="41">Distributions of Polymorphic Alleles at the Genotyped Tag SNP Sites in <italic>STAT3</italic> and <italic>TYK2</italic> Among Study Subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Gene</th><th rowspan="2">SNP</th><th rowspan="2">Allele</th><th colspan="2">Number (%) of alleles in</th><th>Allele comparison<sup>a</sup></th><th colspan="2">Number (%) of alleles in</th><th>Allele comparison<sup>a</sup></th></tr><tr><th>UC</th><th>Control</th><th><italic>P</italic> value</th><th>CD</th><th>Control</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td rowspan="6"><italic>STAT3</italic></td><td rowspan="2">rs8074524</td><td>C</td><td>144 (64.3)</td><td>253 (63.3)</td><td char="." align="char" rowspan="2">0.759</td><td>106 (63.9)</td><td>253 (63.3)</td><td char="." align="char">0.892</td></tr><tr><td>T</td><td>80 (35.7)</td><td>147 (36.7)</td><td>60 (36.1)</td><td>147 (36.7)</td><td/></tr><tr><td rowspan="2">rs2293152</td><td>G</td><td>151 (66.2)</td><td>267 (66.7)</td><td char="." align="char" rowspan="2">0.894</td><td>91 (54.8)</td><td>267 (66.7)</td><td char="." align="char">0.007</td></tr><tr><td>C</td><td>77 (33.8)</td><td>133 (33.3)</td><td>75 (45.2)</td><td>133 (33.3)</td><td/></tr><tr><td rowspan="2">rs957970</td><td>A</td><td>116 (51.8)</td><td>218 (54.5)</td><td char="." align="char" rowspan="2">0.652</td><td>84 (50.6)</td><td>218 (54.5)</td><td char="." align="char">0.397</td></tr><tr><td>G</td><td>108 (48.2)</td><td>182 (45.5)</td><td>82 (49.4)</td><td>182 (45.5)</td><td/></tr><tr><td rowspan="8"><italic>TYK2</italic></td><td rowspan="2">rs280496</td><td>C</td><td>201 (89.7)</td><td>362 (90.5)</td><td char="." align="char" rowspan="2">0.784</td><td>144 (86.7)</td><td>362 (90.5)</td><td char="." align="char">0.187</td></tr><tr><td>G</td><td>23 (10.3)</td><td>38 (9.5)</td><td>22 (13.3)</td><td>38 (9.5)</td><td/></tr><tr><td rowspan="2">rs280519</td><td>A</td><td>136 (60.7)</td><td>224 (56.0)</td><td char="." align="char" rowspan="2">0.261</td><td>109 (65.7)</td><td>224 (56.0)</td><td char="." align="char">0.034</td></tr><tr><td>G</td><td>88 (39.3)</td><td>176 (44.0)</td><td>57 (34.3)</td><td>176 (44.0)</td><td/></tr><tr><td rowspan="2">rs2304256</td><td>C</td><td>156 (69.6)</td><td>262 (65.5)</td><td char="." align="char" rowspan="2">0.311</td><td>129 (77.7)</td><td>262 (65.5)</td><td char="." align="char">0.004</td></tr><tr><td>A</td><td>68 (30.4)</td><td>138 (34.5)</td><td>37 (23.3)</td><td>138 (34.5)</td><td/></tr><tr><td rowspan="2">rs280523</td><td>G</td><td>207 (92.4)</td><td>370 (92.5)</td><td char="." align="char" rowspan="2">0.968</td><td>154 (92.8)</td><td>370 (92.5)</td><td char="." align="char">0.911</td></tr><tr><td>A</td><td>17 (7.6)</td><td>30 (7.5)</td><td>12 (7.2)</td><td>30 (7.5)</td><td/></tr><tr><td colspan="3">Total number of alleles</td><td>228</td><td>400</td><td/><td>166</td><td>400</td><td/></tr></tbody></table><table-wrap-foot><p textid="42"><sup>a</sup>Each allele was compared to another allele using a chi-square test.</p></table-wrap-foot></table-wrap>
###xml 1608 1617 1608 1617 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table III</label>
###xml 1667 1672 1667 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 1677 1681 1677 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 1617 1722 1617 1722 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43">Distribution of Genotypes at the Tag SNP Sites in <italic>STAT3</italic> and <italic>TYK2</italic> Between CD Patients and Control Subjects</p>
###xml 1617 1722 1617 1722 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="43">Distribution of Genotypes at the Tag SNP Sites in <italic>STAT3</italic> and <italic>TYK2</italic> Between CD Patients and Control Subjects</p></caption>
###xml 1722 1726 1722 1726 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Gene</th>
###xml 1726 1729 1726 1729 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">SNP</th>
###xml 1729 1737 1729 1737 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Genotype</th>
###xml 1737 1763 1737 1763 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Number (%) of genotypes in</th>
###xml 1782 1783 1782 1783 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1763 1783 1763 1783 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Genotype comparison<sup>a</sup></th>
###xml 1722 1783 1722 1783 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">Gene</th><th rowspan="2">SNP</th><th rowspan="2">Genotype</th><th colspan="2">Number (%) of genotypes in</th><th colspan="2">Genotype comparison<sup>a</sup></th></tr>
###xml 1783 1785 1783 1785 <th xmlns:xlink="http://www.w3.org/1999/xlink">CD</th>
###xml 1785 1792 1785 1792 <th xmlns:xlink="http://www.w3.org/1999/xlink">Control</th>
###xml 1792 1803 1792 1803 <th xmlns:xlink="http://www.w3.org/1999/xlink">OR (95% CI)</th>
###xml 1803 1804 1803 1804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1803 1810 1803 1810 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>P</italic> value</th>
###xml 1783 1810 1783 1810 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr>
###xml 1722 1810 1722 1810 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">Gene</th><th rowspan="2">SNP</th><th rowspan="2">Genotype</th><th colspan="2">Number (%) of genotypes in</th><th colspan="2">Genotype comparison<sup>a</sup></th></tr><tr><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead>
###xml 1810 1815 1810 1815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 1810 1815 1810 1815 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="9"><italic>STAT3</italic></td>
###xml 1815 1824 1815 1824 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="3">rs8074524</td>
###xml 1824 1827 1824 1827 <td xmlns:xlink="http://www.w3.org/1999/xlink">C/C</td>
###xml 1827 1836 1827 1836 <td xmlns:xlink="http://www.w3.org/1999/xlink">34 (41.0)</td>
###xml 1836 1845 1836 1845 <td xmlns:xlink="http://www.w3.org/1999/xlink">75 (37.5)</td>
###xml 1845 1864 1845 1864 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.156 (0.686&#8211;1.951)</td>
###xml 1864 1869 1864 1869 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.586</td>
###xml 1810 1869 1810 1869 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="9"><italic>STAT3</italic></td><td rowspan="3">rs8074524</td><td>C/C</td><td>34 (41.0)</td><td>75 (37.5)</td><td>1.156 (0.686&#8211;1.951)</td><td>0.586</td></tr>
###xml 1869 1872 1869 1872 <td xmlns:xlink="http://www.w3.org/1999/xlink">C/T</td>
###xml 1872 1881 1872 1881 <td xmlns:xlink="http://www.w3.org/1999/xlink">38 (45.8)</td>
###xml 1881 1891 1881 1891 <td xmlns:xlink="http://www.w3.org/1999/xlink">103 (51.5)</td>
###xml 1891 1910 1891 1910 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.795 (0.476&#8211;1.329)</td>
###xml 1910 1915 1910 1915 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.382</td>
###xml 1869 1915 1869 1915 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>C/T</td><td>38 (45.8)</td><td>103 (51.5)</td><td>0.795 (0.476&#8211;1.329)</td><td>0.382</td></tr>
###xml 1915 1918 1915 1918 <td xmlns:xlink="http://www.w3.org/1999/xlink">T/T</td>
###xml 1918 1927 1918 1927 <td xmlns:xlink="http://www.w3.org/1999/xlink">11 (13.3)</td>
###xml 1927 1936 1927 1936 <td xmlns:xlink="http://www.w3.org/1999/xlink">22 (11.0)</td>
###xml 1936 1955 1936 1955 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.236 (0.570&#8211;2.680)</td>
###xml 1955 1960 1955 1960 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.591</td>
###xml 1915 1960 1915 1960 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>T/T</td><td>11 (13.3)</td><td>22 (11.0)</td><td>1.236 (0.570&#8211;2.680)</td><td>0.591</td></tr>
###xml 1960 1969 1960 1969 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="3">rs2293152</td>
###xml 1969 1972 1969 1972 <td xmlns:xlink="http://www.w3.org/1999/xlink">G/G</td>
###xml 1972 1981 1972 1981 <td xmlns:xlink="http://www.w3.org/1999/xlink">27 (32.5)</td>
###xml 1981 1990 1981 1990 <td xmlns:xlink="http://www.w3.org/1999/xlink">84 (42.0)</td>
###xml 1990 2009 1990 2009 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.666 (0.389&#8211;1.141)</td>
###xml 2009 2014 2009 2014 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.139</td>
###xml 1960 2014 1960 2014 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="3">rs2293152</td><td>G/G</td><td>27 (32.5)</td><td>84 (42.0)</td><td>0.666 (0.389&#8211;1.141)</td><td>0.139</td></tr>
###xml 2014 2017 2014 2017 <td xmlns:xlink="http://www.w3.org/1999/xlink">G/C</td>
###xml 2017 2026 2017 2026 <td xmlns:xlink="http://www.w3.org/1999/xlink">37 (44.6)</td>
###xml 2026 2035 2026 2035 <td xmlns:xlink="http://www.w3.org/1999/xlink">99 (49.5)</td>
###xml 2035 2054 2035 2054 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.821 (0.491&#8211;1.372)</td>
###xml 2054 2059 2054 2059 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.451</td>
###xml 2014 2059 2014 2059 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>G/C</td><td>37 (44.6)</td><td>99 (49.5)</td><td>0.821 (0.491&#8211;1.372)</td><td>0.451</td></tr>
###xml 2059 2062 2059 2062 <td xmlns:xlink="http://www.w3.org/1999/xlink">C/C</td>
###xml 2062 2071 2062 2071 <td xmlns:xlink="http://www.w3.org/1999/xlink">19 (22.9)</td>
###xml 2071 2079 2071 2079 <td xmlns:xlink="http://www.w3.org/1999/xlink">17 (8.5)</td>
###xml 2079 2098 2079 2098 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.196 (1.566&#8211;6.523)</td>
###xml 2098 2103 2098 2103 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.001</td>
###xml 2059 2103 2059 2103 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>C/C</td><td>19 (22.9)</td><td>17 (8.5)</td><td>3.196 (1.566&#8211;6.523)</td><td>0.001</td></tr>
###xml 2103 2111 2103 2111 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="3">rs957970</td>
###xml 2111 2114 2111 2114 <td xmlns:xlink="http://www.w3.org/1999/xlink">A/A</td>
###xml 2114 2123 2114 2123 <td xmlns:xlink="http://www.w3.org/1999/xlink">19 (22.9)</td>
###xml 2123 2132 2123 2132 <td xmlns:xlink="http://www.w3.org/1999/xlink">55 (27.5)</td>
###xml 2132 2151 2132 2151 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.783 (0.430&#8211;1.424)</td>
###xml 2151 2156 2151 2156 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.423</td>
###xml 2103 2156 2103 2156 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="3">rs957970</td><td>A/A</td><td>19 (22.9)</td><td>55 (27.5)</td><td>0.783 (0.430&#8211;1.424)</td><td>0.423</td></tr>
###xml 2156 2159 2156 2159 <td xmlns:xlink="http://www.w3.org/1999/xlink">G/A</td>
###xml 2159 2168 2159 2168 <td xmlns:xlink="http://www.w3.org/1999/xlink">46 (55.4)</td>
###xml 2168 2178 2168 2178 <td xmlns:xlink="http://www.w3.org/1999/xlink">108 (54.0)</td>
###xml 2178 2197 2178 2197 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.059 (0.633&#8211;1.772)</td>
###xml 2197 2202 2197 2202 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.827</td>
###xml 2156 2202 2156 2202 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>G/A</td><td>46 (55.4)</td><td>108 (54.0)</td><td>1.059 (0.633&#8211;1.772)</td><td>0.827</td></tr>
###xml 2202 2205 2202 2205 <td xmlns:xlink="http://www.w3.org/1999/xlink">G/G</td>
###xml 2205 2214 2205 2214 <td xmlns:xlink="http://www.w3.org/1999/xlink">18 (21.7)</td>
###xml 2214 2223 2214 2223 <td xmlns:xlink="http://www.w3.org/1999/xlink">37 (18.5)</td>
###xml 2223 2242 2223 2242 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.220 (0.648&#8211;2.296)</td>
###xml 2242 2247 2242 2247 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.538</td>
###xml 2202 2247 2202 2247 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>G/G</td><td>18 (21.7)</td><td>37 (18.5)</td><td>1.220 (0.648&#8211;2.296)</td><td>0.538</td></tr>
###xml 2247 2251 2247 2251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 2247 2251 2247 2251 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="12"><italic>TYK2</italic></td>
###xml 2251 2259 2251 2259 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="3">rs280496</td>
###xml 2259 2262 2259 2262 <td xmlns:xlink="http://www.w3.org/1999/xlink">C/C</td>
###xml 2262 2271 2262 2271 <td xmlns:xlink="http://www.w3.org/1999/xlink">61 (73.5)</td>
###xml 2271 2281 2271 2281 <td xmlns:xlink="http://www.w3.org/1999/xlink">162 (81.0)</td>
###xml 2281 2300 2281 2300 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.650 (0.356&#8211;1.187)</td>
###xml 2300 2305 2300 2305 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.161</td>
###xml 2247 2305 2247 2305 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="12"><italic>TYK2</italic></td><td rowspan="3">rs280496</td><td>C/C</td><td>61 (73.5)</td><td>162 (81.0)</td><td>0.650 (0.356&#8211;1.187)</td><td>0.161</td></tr>
###xml 2305 2308 2305 2308 <td xmlns:xlink="http://www.w3.org/1999/xlink">C/G</td>
###xml 2308 2317 2308 2317 <td xmlns:xlink="http://www.w3.org/1999/xlink">22 (26.5)</td>
###xml 2317 2326 2317 2326 <td xmlns:xlink="http://www.w3.org/1999/xlink">38 (19.0)</td>
###xml 2326 2345 2326 2345 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.538 (0.842&#8211;2.807)</td>
###xml 2345 2350 2345 2350 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.161</td>
###xml 2305 2350 2305 2350 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>C/G</td><td>22 (26.5)</td><td>38 (19.0)</td><td>1.538 (0.842&#8211;2.807)</td><td>0.161</td></tr>
###xml 2350 2353 2350 2353 <td xmlns:xlink="http://www.w3.org/1999/xlink">G/G</td>
###xml 2353 2354 2353 2354 <td xmlns:xlink="http://www.w3.org/1999/xlink">0</td>
###xml 2354 2355 2354 2355 <td xmlns:xlink="http://www.w3.org/1999/xlink">0</td>
###xml 2355 2356 2355 2356 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 2356 2357 2356 2357 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 2350 2357 2350 2357 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>G/G</td><td>0</td><td>0</td><td>&#8211;</td><td>&#8211;</td></tr>
###xml 2357 2365 2357 2365 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="3">rs280519</td>
###xml 2365 2368 2365 2368 <td xmlns:xlink="http://www.w3.org/1999/xlink">A/A</td>
###xml 2368 2377 2368 2377 <td xmlns:xlink="http://www.w3.org/1999/xlink">37 (44.6)</td>
###xml 2377 2386 2377 2386 <td xmlns:xlink="http://www.w3.org/1999/xlink">63 (31.5)</td>
###xml 2386 2405 2386 2405 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.749 (1.034&#8211;2.959)</td>
###xml 2405 2410 2405 2410 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.037</td>
###xml 2357 2410 2357 2410 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="3">rs280519</td><td>A/A</td><td>37 (44.6)</td><td>63 (31.5)</td><td>1.749 (1.034&#8211;2.959)</td><td>0.037</td></tr>
###xml 2410 2413 2410 2413 <td xmlns:xlink="http://www.w3.org/1999/xlink">A/G</td>
###xml 2413 2422 2413 2422 <td xmlns:xlink="http://www.w3.org/1999/xlink">35 (42.2)</td>
###xml 2422 2431 2422 2431 <td xmlns:xlink="http://www.w3.org/1999/xlink">98 (49.0)</td>
###xml 2431 2450 2431 2450 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.759 (0.453&#8211;1.272)</td>
###xml 2450 2455 2450 2455 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.295</td>
###xml 2410 2455 2410 2455 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>A/G</td><td>35 (42.2)</td><td>98 (49.0)</td><td>0.759 (0.453&#8211;1.272)</td><td>0.295</td></tr>
###xml 2455 2458 2455 2458 <td xmlns:xlink="http://www.w3.org/1999/xlink">G/G</td>
###xml 2458 2467 2458 2467 <td xmlns:xlink="http://www.w3.org/1999/xlink">11 (13.2)</td>
###xml 2467 2476 2467 2476 <td xmlns:xlink="http://www.w3.org/1999/xlink">39 (19.5)</td>
###xml 2476 2495 2476 2495 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.631 (0.306&#8211;1.302)</td>
###xml 2495 2500 2495 2500 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.212</td>
###xml 2455 2500 2455 2500 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>G/G</td><td>11 (13.2)</td><td>39 (19.5)</td><td>0.631 (0.306&#8211;1.302)</td><td>0.212</td></tr>
###xml 2500 2509 2500 2509 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="3">rs2304256</td>
###xml 2509 2512 2509 2512 <td xmlns:xlink="http://www.w3.org/1999/xlink">C/C</td>
###xml 2512 2521 2512 2521 <td xmlns:xlink="http://www.w3.org/1999/xlink">52 (62.7)</td>
###xml 2521 2530 2521 2530 <td xmlns:xlink="http://www.w3.org/1999/xlink">86 (43.0)</td>
###xml 2530 2549 2530 2549 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.224 (1.315&#8211;3.716)</td>
###xml 2549 2554 2549 2554 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.003</td>
###xml 2500 2554 2500 2554 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="3">rs2304256</td><td>C/C</td><td>52 (62.7)</td><td>86 (43.0)</td><td>2.224 (1.315&#8211;3.716)</td><td>0.003</td></tr>
###xml 2554 2557 2554 2557 <td xmlns:xlink="http://www.w3.org/1999/xlink">C/A</td>
###xml 2557 2566 2557 2566 <td xmlns:xlink="http://www.w3.org/1999/xlink">25 (30.1)</td>
###xml 2566 2575 2566 2575 <td xmlns:xlink="http://www.w3.org/1999/xlink">90 (45.0)</td>
###xml 2575 2594 2575 2594 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.527 (0.305&#8211;0.909)</td>
###xml 2594 2599 2594 2599 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.021</td>
###xml 2554 2599 2554 2599 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>C/A</td><td>25 (30.1)</td><td>90 (45.0)</td><td>0.527 (0.305&#8211;0.909)</td><td>0.021</td></tr>
###xml 2599 2602 2599 2602 <td xmlns:xlink="http://www.w3.org/1999/xlink">A/A</td>
###xml 2602 2609 2602 2609 <td xmlns:xlink="http://www.w3.org/1999/xlink">6 (7.2)</td>
###xml 2609 2618 2609 2618 <td xmlns:xlink="http://www.w3.org/1999/xlink">24 (12.0)</td>
###xml 2618 2637 2618 2637 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.571 (0.225&#8211;1.454)</td>
###xml 2637 2642 2637 2642 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.240</td>
###xml 2599 2642 2599 2642 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>A/A</td><td>6 (7.2)</td><td>24 (12.0)</td><td>0.571 (0.225&#8211;1.454)</td><td>0.240</td></tr>
###xml 2642 2650 2642 2650 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="3">rs280523</td>
###xml 2650 2653 2650 2653 <td xmlns:xlink="http://www.w3.org/1999/xlink">G/G</td>
###xml 2653 2662 2653 2662 <td xmlns:xlink="http://www.w3.org/1999/xlink">71 (85.5)</td>
###xml 2662 2672 2662 2672 <td xmlns:xlink="http://www.w3.org/1999/xlink">170 (85.0)</td>
###xml 2672 2691 2672 2691 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.044 (0.506&#8211;2.155)</td>
###xml 2691 2696 2691 2696 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.907</td>
###xml 2642 2696 2642 2696 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="3">rs280523</td><td>G/G</td><td>71 (85.5)</td><td>170 (85.0)</td><td>1.044 (0.506&#8211;2.155)</td><td>0.907</td></tr>
###xml 2696 2699 2696 2699 <td xmlns:xlink="http://www.w3.org/1999/xlink">G/A</td>
###xml 2699 2708 2699 2708 <td xmlns:xlink="http://www.w3.org/1999/xlink">12 (14.5)</td>
###xml 2708 2717 2708 2717 <td xmlns:xlink="http://www.w3.org/1999/xlink">30 (15.0)</td>
###xml 2717 2736 2717 2736 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.958 (0.464&#8211;1.976)</td>
###xml 2736 2741 2736 2741 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.907</td>
###xml 2696 2741 2696 2741 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>G/A</td><td>12 (14.5)</td><td>30 (15.0)</td><td>0.958 (0.464&#8211;1.976)</td><td>0.907</td></tr>
###xml 2741 2744 2741 2744 <td xmlns:xlink="http://www.w3.org/1999/xlink">A/A</td>
###xml 2744 2745 2744 2745 <td xmlns:xlink="http://www.w3.org/1999/xlink">0</td>
###xml 2745 2746 2745 2746 <td xmlns:xlink="http://www.w3.org/1999/xlink">0</td>
###xml 2746 2747 2746 2747 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 2747 2748 2747 2748 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 2741 2748 2741 2748 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>A/A</td><td>0</td><td>0</td><td>&#8211;</td><td>&#8211;</td></tr>
###xml 2748 2772 2748 2772 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">Total number of subjects</td>
###xml 2772 2774 2772 2774 <td xmlns:xlink="http://www.w3.org/1999/xlink">83</td>
###xml 2774 2777 2774 2777 <td xmlns:xlink="http://www.w3.org/1999/xlink">200</td>
###xml 2777 2777 2777 2777 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 2777 2777 2777 2777 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 2748 2777 2748 2777 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="3">Total number of subjects</td><td>83</td><td>200</td><td/><td/></tr>
###xml 1810 2777 1810 2777 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td rowspan="9"><italic>STAT3</italic></td><td rowspan="3">rs8074524</td><td>C/C</td><td>34 (41.0)</td><td>75 (37.5)</td><td>1.156 (0.686&#8211;1.951)</td><td>0.586</td></tr><tr><td>C/T</td><td>38 (45.8)</td><td>103 (51.5)</td><td>0.795 (0.476&#8211;1.329)</td><td>0.382</td></tr><tr><td>T/T</td><td>11 (13.3)</td><td>22 (11.0)</td><td>1.236 (0.570&#8211;2.680)</td><td>0.591</td></tr><tr><td rowspan="3">rs2293152</td><td>G/G</td><td>27 (32.5)</td><td>84 (42.0)</td><td>0.666 (0.389&#8211;1.141)</td><td>0.139</td></tr><tr><td>G/C</td><td>37 (44.6)</td><td>99 (49.5)</td><td>0.821 (0.491&#8211;1.372)</td><td>0.451</td></tr><tr><td>C/C</td><td>19 (22.9)</td><td>17 (8.5)</td><td>3.196 (1.566&#8211;6.523)</td><td>0.001</td></tr><tr><td rowspan="3">rs957970</td><td>A/A</td><td>19 (22.9)</td><td>55 (27.5)</td><td>0.783 (0.430&#8211;1.424)</td><td>0.423</td></tr><tr><td>G/A</td><td>46 (55.4)</td><td>108 (54.0)</td><td>1.059 (0.633&#8211;1.772)</td><td>0.827</td></tr><tr><td>G/G</td><td>18 (21.7)</td><td>37 (18.5)</td><td>1.220 (0.648&#8211;2.296)</td><td>0.538</td></tr><tr><td rowspan="12"><italic>TYK2</italic></td><td rowspan="3">rs280496</td><td>C/C</td><td>61 (73.5)</td><td>162 (81.0)</td><td>0.650 (0.356&#8211;1.187)</td><td>0.161</td></tr><tr><td>C/G</td><td>22 (26.5)</td><td>38 (19.0)</td><td>1.538 (0.842&#8211;2.807)</td><td>0.161</td></tr><tr><td>G/G</td><td>0</td><td>0</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td rowspan="3">rs280519</td><td>A/A</td><td>37 (44.6)</td><td>63 (31.5)</td><td>1.749 (1.034&#8211;2.959)</td><td>0.037</td></tr><tr><td>A/G</td><td>35 (42.2)</td><td>98 (49.0)</td><td>0.759 (0.453&#8211;1.272)</td><td>0.295</td></tr><tr><td>G/G</td><td>11 (13.2)</td><td>39 (19.5)</td><td>0.631 (0.306&#8211;1.302)</td><td>0.212</td></tr><tr><td rowspan="3">rs2304256</td><td>C/C</td><td>52 (62.7)</td><td>86 (43.0)</td><td>2.224 (1.315&#8211;3.716)</td><td>0.003</td></tr><tr><td>C/A</td><td>25 (30.1)</td><td>90 (45.0)</td><td>0.527 (0.305&#8211;0.909)</td><td>0.021</td></tr><tr><td>A/A</td><td>6 (7.2)</td><td>24 (12.0)</td><td>0.571 (0.225&#8211;1.454)</td><td>0.240</td></tr><tr><td rowspan="3">rs280523</td><td>G/G</td><td>71 (85.5)</td><td>170 (85.0)</td><td>1.044 (0.506&#8211;2.155)</td><td>0.907</td></tr><tr><td>G/A</td><td>12 (14.5)</td><td>30 (15.0)</td><td>0.958 (0.464&#8211;1.976)</td><td>0.907</td></tr><tr><td>A/A</td><td>0</td><td>0</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td colspan="3">Total number of subjects</td><td>83</td><td>200</td><td/><td/></tr></tbody>
###xml 1722 2777 1722 2777 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">Gene</th><th rowspan="2">SNP</th><th rowspan="2">Genotype</th><th colspan="2">Number (%) of genotypes in</th><th colspan="2">Genotype comparison<sup>a</sup></th></tr><tr><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td rowspan="9"><italic>STAT3</italic></td><td rowspan="3">rs8074524</td><td>C/C</td><td>34 (41.0)</td><td>75 (37.5)</td><td>1.156 (0.686&#8211;1.951)</td><td>0.586</td></tr><tr><td>C/T</td><td>38 (45.8)</td><td>103 (51.5)</td><td>0.795 (0.476&#8211;1.329)</td><td>0.382</td></tr><tr><td>T/T</td><td>11 (13.3)</td><td>22 (11.0)</td><td>1.236 (0.570&#8211;2.680)</td><td>0.591</td></tr><tr><td rowspan="3">rs2293152</td><td>G/G</td><td>27 (32.5)</td><td>84 (42.0)</td><td>0.666 (0.389&#8211;1.141)</td><td>0.139</td></tr><tr><td>G/C</td><td>37 (44.6)</td><td>99 (49.5)</td><td>0.821 (0.491&#8211;1.372)</td><td>0.451</td></tr><tr><td>C/C</td><td>19 (22.9)</td><td>17 (8.5)</td><td>3.196 (1.566&#8211;6.523)</td><td>0.001</td></tr><tr><td rowspan="3">rs957970</td><td>A/A</td><td>19 (22.9)</td><td>55 (27.5)</td><td>0.783 (0.430&#8211;1.424)</td><td>0.423</td></tr><tr><td>G/A</td><td>46 (55.4)</td><td>108 (54.0)</td><td>1.059 (0.633&#8211;1.772)</td><td>0.827</td></tr><tr><td>G/G</td><td>18 (21.7)</td><td>37 (18.5)</td><td>1.220 (0.648&#8211;2.296)</td><td>0.538</td></tr><tr><td rowspan="12"><italic>TYK2</italic></td><td rowspan="3">rs280496</td><td>C/C</td><td>61 (73.5)</td><td>162 (81.0)</td><td>0.650 (0.356&#8211;1.187)</td><td>0.161</td></tr><tr><td>C/G</td><td>22 (26.5)</td><td>38 (19.0)</td><td>1.538 (0.842&#8211;2.807)</td><td>0.161</td></tr><tr><td>G/G</td><td>0</td><td>0</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td rowspan="3">rs280519</td><td>A/A</td><td>37 (44.6)</td><td>63 (31.5)</td><td>1.749 (1.034&#8211;2.959)</td><td>0.037</td></tr><tr><td>A/G</td><td>35 (42.2)</td><td>98 (49.0)</td><td>0.759 (0.453&#8211;1.272)</td><td>0.295</td></tr><tr><td>G/G</td><td>11 (13.2)</td><td>39 (19.5)</td><td>0.631 (0.306&#8211;1.302)</td><td>0.212</td></tr><tr><td rowspan="3">rs2304256</td><td>C/C</td><td>52 (62.7)</td><td>86 (43.0)</td><td>2.224 (1.315&#8211;3.716)</td><td>0.003</td></tr><tr><td>C/A</td><td>25 (30.1)</td><td>90 (45.0)</td><td>0.527 (0.305&#8211;0.909)</td><td>0.021</td></tr><tr><td>A/A</td><td>6 (7.2)</td><td>24 (12.0)</td><td>0.571 (0.225&#8211;1.454)</td><td>0.240</td></tr><tr><td rowspan="3">rs280523</td><td>G/G</td><td>71 (85.5)</td><td>170 (85.0)</td><td>1.044 (0.506&#8211;2.155)</td><td>0.907</td></tr><tr><td>G/A</td><td>12 (14.5)</td><td>30 (15.0)</td><td>0.958 (0.464&#8211;1.976)</td><td>0.907</td></tr><tr><td>A/A</td><td>0</td><td>0</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td colspan="3">Total number of subjects</td><td>83</td><td>200</td><td/><td/></tr></tbody></table>
###xml 2777 2779 2777 2779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 2792 2794 2792 2794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 2777 2814 2777 2814 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p>
###xml 2814 2815 2814 2815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2814 2906 2814 2906 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="45"><sup>a</sup>Each genotype was compared to other genotypes combined using a logistic regression analysis</p>
###xml 2777 2906 2777 2906 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p><p textid="45"><sup>a</sup>Each genotype was compared to other genotypes combined using a logistic regression analysis</p></table-wrap-foot>
###xml 1608 2906 1608 2906 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table III</label><caption><p textid="43">Distribution of Genotypes at the Tag SNP Sites in <italic>STAT3</italic> and <italic>TYK2</italic> Between CD Patients and Control Subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Gene</th><th rowspan="2">SNP</th><th rowspan="2">Genotype</th><th colspan="2">Number (%) of genotypes in</th><th colspan="2">Genotype comparison<sup>a</sup></th></tr><tr><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td rowspan="9"><italic>STAT3</italic></td><td rowspan="3">rs8074524</td><td>C/C</td><td>34 (41.0)</td><td>75 (37.5)</td><td>1.156 (0.686&#8211;1.951)</td><td>0.586</td></tr><tr><td>C/T</td><td>38 (45.8)</td><td>103 (51.5)</td><td>0.795 (0.476&#8211;1.329)</td><td>0.382</td></tr><tr><td>T/T</td><td>11 (13.3)</td><td>22 (11.0)</td><td>1.236 (0.570&#8211;2.680)</td><td>0.591</td></tr><tr><td rowspan="3">rs2293152</td><td>G/G</td><td>27 (32.5)</td><td>84 (42.0)</td><td>0.666 (0.389&#8211;1.141)</td><td>0.139</td></tr><tr><td>G/C</td><td>37 (44.6)</td><td>99 (49.5)</td><td>0.821 (0.491&#8211;1.372)</td><td>0.451</td></tr><tr><td>C/C</td><td>19 (22.9)</td><td>17 (8.5)</td><td>3.196 (1.566&#8211;6.523)</td><td>0.001</td></tr><tr><td rowspan="3">rs957970</td><td>A/A</td><td>19 (22.9)</td><td>55 (27.5)</td><td>0.783 (0.430&#8211;1.424)</td><td>0.423</td></tr><tr><td>G/A</td><td>46 (55.4)</td><td>108 (54.0)</td><td>1.059 (0.633&#8211;1.772)</td><td>0.827</td></tr><tr><td>G/G</td><td>18 (21.7)</td><td>37 (18.5)</td><td>1.220 (0.648&#8211;2.296)</td><td>0.538</td></tr><tr><td rowspan="12"><italic>TYK2</italic></td><td rowspan="3">rs280496</td><td>C/C</td><td>61 (73.5)</td><td>162 (81.0)</td><td>0.650 (0.356&#8211;1.187)</td><td>0.161</td></tr><tr><td>C/G</td><td>22 (26.5)</td><td>38 (19.0)</td><td>1.538 (0.842&#8211;2.807)</td><td>0.161</td></tr><tr><td>G/G</td><td>0</td><td>0</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td rowspan="3">rs280519</td><td>A/A</td><td>37 (44.6)</td><td>63 (31.5)</td><td>1.749 (1.034&#8211;2.959)</td><td>0.037</td></tr><tr><td>A/G</td><td>35 (42.2)</td><td>98 (49.0)</td><td>0.759 (0.453&#8211;1.272)</td><td>0.295</td></tr><tr><td>G/G</td><td>11 (13.2)</td><td>39 (19.5)</td><td>0.631 (0.306&#8211;1.302)</td><td>0.212</td></tr><tr><td rowspan="3">rs2304256</td><td>C/C</td><td>52 (62.7)</td><td>86 (43.0)</td><td>2.224 (1.315&#8211;3.716)</td><td>0.003</td></tr><tr><td>C/A</td><td>25 (30.1)</td><td>90 (45.0)</td><td>0.527 (0.305&#8211;0.909)</td><td>0.021</td></tr><tr><td>A/A</td><td>6 (7.2)</td><td>24 (12.0)</td><td>0.571 (0.225&#8211;1.454)</td><td>0.240</td></tr><tr><td rowspan="3">rs280523</td><td>G/G</td><td>71 (85.5)</td><td>170 (85.0)</td><td>1.044 (0.506&#8211;2.155)</td><td>0.907</td></tr><tr><td>G/A</td><td>12 (14.5)</td><td>30 (15.0)</td><td>0.958 (0.464&#8211;1.976)</td><td>0.907</td></tr><tr><td>A/A</td><td>0</td><td>0</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td colspan="3">Total number of subjects</td><td>83</td><td>200</td><td/><td/></tr></tbody></table><table-wrap-foot><p textid="44"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p><p textid="45"><sup>a</sup>Each genotype was compared to other genotypes combined using a logistic regression analysis</p></table-wrap-foot></table-wrap>
###xml 136 144 <span type="species:ncbi:9606">patients</span>
###xml 418 426 <span type="species:ncbi:9606">patients</span>
###xml 1693 1701 <span type="species:ncbi:9606">Patients</span>
The frequencies and distributions of alleles and genotypes at the three tag SNPs in STAT3 were identified and compared between UC or CD patients and control subjects (Tables II and III, respectively). The C allele at rs8074524 SNP, G allele at rs2293152 SNP, and A allele at rs957970 SNP are major alleles, whereas the other alleles are minor alleles (Table II). The distributions of these tag SNPs in STAT3 among IBD patients and control subjects corresponded well to the Hardy-Weinberg equilibrium, thus implying that the subject base has a homogeneous genetic background. Table IIDistributions of Polymorphic Alleles at the Genotyped Tag SNP Sites in STAT3 and TYK2 Among Study SubjectsGeneSNPAlleleNumber (%) of alleles inAllele comparisonaNumber (%) of alleles inAllele comparisonaUCControlP valueCDControlP valueSTAT3rs8074524C144 (64.3)253 (63.3)0.759106 (63.9)253 (63.3)0.892T80 (35.7)147 (36.7)60 (36.1)147 (36.7)rs2293152G151 (66.2)267 (66.7)0.89491 (54.8)267 (66.7)0.007C77 (33.8)133 (33.3)75 (45.2)133 (33.3)rs957970A116 (51.8)218 (54.5)0.65284 (50.6)218 (54.5)0.397G108 (48.2)182 (45.5)82 (49.4)182 (45.5)TYK2rs280496C201 (89.7)362 (90.5)0.784144 (86.7)362 (90.5)0.187G23 (10.3)38 (9.5)22 (13.3)38 (9.5)rs280519A136 (60.7)224 (56.0)0.261109 (65.7)224 (56.0)0.034G88 (39.3)176 (44.0)57 (34.3)176 (44.0)rs2304256C156 (69.6)262 (65.5)0.311129 (77.7)262 (65.5)0.004A68 (30.4)138 (34.5)37 (23.3)138 (34.5)rs280523G207 (92.4)370 (92.5)0.968154 (92.8)370 (92.5)0.911A17 (7.6)30 (7.5)12 (7.2)30 (7.5)Total number of alleles228400166400aEach allele was compared to another allele using a chi-square test.Table IIIDistribution of Genotypes at the Tag SNP Sites in STAT3 and TYK2 Between CD Patients and Control SubjectsGeneSNPGenotypeNumber (%) of genotypes inGenotype comparisonaCDControlOR (95% CI)P valueSTAT3rs8074524C/C34 (41.0)75 (37.5)1.156 (0.686-1.951)0.586C/T38 (45.8)103 (51.5)0.795 (0.476-1.329)0.382T/T11 (13.3)22 (11.0)1.236 (0.570-2.680)0.591rs2293152G/G27 (32.5)84 (42.0)0.666 (0.389-1.141)0.139G/C37 (44.6)99 (49.5)0.821 (0.491-1.372)0.451C/C19 (22.9)17 (8.5)3.196 (1.566-6.523)0.001rs957970A/A19 (22.9)55 (27.5)0.783 (0.430-1.424)0.423G/A46 (55.4)108 (54.0)1.059 (0.633-1.772)0.827G/G18 (21.7)37 (18.5)1.220 (0.648-2.296)0.538TYK2rs280496C/C61 (73.5)162 (81.0)0.650 (0.356-1.187)0.161C/G22 (26.5)38 (19.0)1.538 (0.842-2.807)0.161G/G00--rs280519A/A37 (44.6)63 (31.5)1.749 (1.034-2.959)0.037A/G35 (42.2)98 (49.0)0.759 (0.453-1.272)0.295G/G11 (13.2)39 (19.5)0.631 (0.306-1.302)0.212rs2304256C/C52 (62.7)86 (43.0)2.224 (1.315-3.716)0.003C/A25 (30.1)90 (45.0)0.527 (0.305-0.909)0.021A/A6 (7.2)24 (12.0)0.571 (0.225-1.454)0.240rs280523G/G71 (85.5)170 (85.0)1.044 (0.506-2.155)0.907G/A12 (14.5)30 (15.0)0.958 (0.464-1.976)0.907A/A00--Total number of subjects83200OR odds ratio, CI confidence intervalaEach genotype was compared to other genotypes combined using a logistic regression analysis
###end p 40
###begin p 41
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
Distributions of Polymorphic Alleles at the Genotyped Tag SNP Sites in STAT3 and TYK2 Among Study Subjects
###end p 41
###begin p 42
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aEach allele was compared to another allele using a chi-square test.
###end p 42
###begin p 43
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 76 84 <span type="species:ncbi:9606">Patients</span>
Distribution of Genotypes at the Tag SNP Sites in STAT3 and TYK2 Between CD Patients and Control Subjects
###end p 43
###begin p 44
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 15 17 15 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
OR odds ratio, CI confidence interval
###end p 44
###begin p 45
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aEach genotype was compared to other genotypes combined using a logistic regression analysis
###end p 45
###begin p 46
###xml 167 168 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 197 198 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 320 328 <span type="species:ncbi:9606">patients</span>
The frequencies of the C allele and its homozygous C/C genotype at rs2293152 in CD patients were significantly higher than those in control subjects (45.2% vs. 33.3%, P = 0.007 and 22.9% vs. 8.5%, P = 0.001, respectively). No significant differences were observed in the frequency of other alleles and genotypes between patients and control subjects.
###end p 46
###begin title 47
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
Association of Tag SNPs in TYK2 with Susceptibility to IBD
###end title 47
###begin p 48
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">II</xref>
###xml 179 182 179 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">III</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">II</xref>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 685 686 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 716 717 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 924 925 924 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 955 956 955 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1153 1154 1153 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 134 142 <span type="species:ncbi:9606">patients</span>
###xml 436 444 <span type="species:ncbi:9606">patients</span>
###xml 601 609 <span type="species:ncbi:9606">patients</span>
###xml 835 843 <span type="species:ncbi:9606">patients</span>
###xml 1084 1092 <span type="species:ncbi:9606">patients</span>
The frequencies and distributions of alleles and genotypes at the four tag SNPs in TYK2 were identified and compared between UC or CD patients and control subjects (Tables II and III, respectively). The C allele at rs280496 SNP, A allele at rs280519 SNP, C allele at rs2304256 SNP, and G allele at rs280523 SNP are major alleles, whereas other alleles are minor alleles (Table II). The distributions of these tag SNPs in TYK2 among IBD patients and control subjects corresponded well to the Hardy-Weinberg equilibrium. The frequencies of the A allele and its homozygous A/A genotype at rs280519 in CD patients were significantly higher than those in control subjects (65.7% vs. 56.0%, P = 0.034 and 44.6% vs. 31.5%, P = 0.037, respectively). Likewise, the frequencies of the C allele and its homozygous C/C genotype at rs2304256 in CD patients were also significantly higher than those in control subjects (77.7% vs. 65.5%, P = 0.004 and 62.7% vs. 43.0%, P = 0.003, respectively). In contrast, the frequency of the C/A heterozygous genotype at rs2304256 was significantly lower in CD patients in comparison to that in control subjects (30.1% vs. 45.0%, P = 0.021).
###end p 48
###begin title 49
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
Association of Haplotypes and Diplotypes of TYK2 with Susceptibility to CD
###end title 49
###begin p 50
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab4" ref-type="table">IV</xref>
###xml 542 543 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 767 768 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 791 799 791 799 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table IV</label>
###xml 830 834 830 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 799 875 799 875 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="51">Distributions of Haplotypes of <italic>TYK2</italic> Between CD Patients and Control Subjects</p>
###xml 799 875 799 875 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="51">Distributions of Haplotypes of <italic>TYK2</italic> Between CD Patients and Control Subjects</p></caption>
###xml 875 884 875 884 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Haplotype</th>
###xml 884 887 884 887 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">SNP</th>
###xml 887 914 887 914 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Number (%) of haplotypes in</th>
###xml 934 935 934 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 914 935 914 935 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Haplotype comparison<sup>a</sup></th>
###xml 875 935 875 935 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">Haplotype</th><th colspan="2">SNP</th><th colspan="2">Number (%) of haplotypes in</th><th colspan="2">Haplotype comparison<sup>a</sup></th></tr>
###xml 935 943 935 943 <th xmlns:xlink="http://www.w3.org/1999/xlink">rs280519</th>
###xml 943 952 943 952 <th xmlns:xlink="http://www.w3.org/1999/xlink">rs2304256</th>
###xml 952 954 952 954 <th xmlns:xlink="http://www.w3.org/1999/xlink">CD</th>
###xml 954 961 954 961 <th xmlns:xlink="http://www.w3.org/1999/xlink">Control</th>
###xml 961 972 961 972 <th xmlns:xlink="http://www.w3.org/1999/xlink">OR (95% CI)</th>
###xml 972 973 972 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 972 979 972 979 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>P</italic> value</th>
###xml 935 979 935 979 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>rs280519</th><th>rs2304256</th><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr>
###xml 875 979 875 979 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">Haplotype</th><th colspan="2">SNP</th><th colspan="2">Number (%) of haplotypes in</th><th colspan="2">Haplotype comparison<sup>a</sup></th></tr><tr><th>rs280519</th><th>rs2304256</th><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead>
###xml 979 984 979 984 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hap 1</td>
###xml 984 985 984 985 <td xmlns:xlink="http://www.w3.org/1999/xlink">A</td>
###xml 985 986 985 986 <td xmlns:xlink="http://www.w3.org/1999/xlink">C</td>
###xml 986 996 986 996 <td xmlns:xlink="http://www.w3.org/1999/xlink">109 (65.7)</td>
###xml 996 1006 996 1006 <td xmlns:xlink="http://www.w3.org/1999/xlink">221 (55.3)</td>
###xml 1006 1025 1006 1025 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.549 (1.063&#8211;2.256)</td>
###xml 1025 1030 1025 1030 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.023</td>
###xml 979 1030 979 1030 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Hap 1</td><td>A</td><td>C</td><td>109 (65.7)</td><td>221 (55.3)</td><td>1.549 (1.063&#8211;2.256)</td><td>0.023</td></tr>
###xml 1030 1035 1030 1035 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hap 2</td>
###xml 1035 1036 1035 1036 <td xmlns:xlink="http://www.w3.org/1999/xlink">G</td>
###xml 1036 1037 1036 1037 <td xmlns:xlink="http://www.w3.org/1999/xlink">A</td>
###xml 1037 1046 1037 1046 <td xmlns:xlink="http://www.w3.org/1999/xlink">37 (22.3)</td>
###xml 1046 1056 1046 1056 <td xmlns:xlink="http://www.w3.org/1999/xlink">135 (33.7)</td>
###xml 1056 1075 1056 1075 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.563 (0.370&#8211;0.857)</td>
###xml 1075 1080 1075 1080 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.007</td>
###xml 1030 1080 1030 1080 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Hap 2</td><td>G</td><td>A</td><td>37 (22.3)</td><td>135 (33.7)</td><td>0.563 (0.370&#8211;0.857)</td><td>0.007</td></tr>
###xml 1080 1085 1080 1085 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hap 3</td>
###xml 1085 1086 1085 1086 <td xmlns:xlink="http://www.w3.org/1999/xlink">G</td>
###xml 1086 1087 1086 1087 <td xmlns:xlink="http://www.w3.org/1999/xlink">C</td>
###xml 1087 1096 1087 1096 <td xmlns:xlink="http://www.w3.org/1999/xlink">20 (12.0)</td>
###xml 1096 1105 1096 1105 <td xmlns:xlink="http://www.w3.org/1999/xlink">41 (10.3)</td>
###xml 1105 1124 1105 1124 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.199 (0.680&#8211;2.117)</td>
###xml 1124 1129 1124 1129 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.530</td>
###xml 1080 1129 1080 1129 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Hap 3</td><td>G</td><td>C</td><td>20 (12.0)</td><td>41 (10.3)</td><td>1.199 (0.680&#8211;2.117)</td><td>0.530</td></tr>
###xml 1129 1134 1129 1134 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hap 4</td>
###xml 1134 1135 1134 1135 <td xmlns:xlink="http://www.w3.org/1999/xlink">A</td>
###xml 1135 1136 1135 1136 <td xmlns:xlink="http://www.w3.org/1999/xlink">A</td>
###xml 1136 1137 1136 1137 <td xmlns:xlink="http://www.w3.org/1999/xlink">0</td>
###xml 1137 1144 1137 1144 <td xmlns:xlink="http://www.w3.org/1999/xlink">3 (0.7)</td>
###xml 1144 1145 1144 1145 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 1145 1146 1145 1146 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 1129 1146 1129 1146 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Hap 4</td><td>A</td><td>A</td><td>0</td><td>3 (0.7)</td><td>&#8211;</td><td>&#8211;</td></tr>
###xml 1146 1172 1146 1172 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">Total number of haplotypes</td>
###xml 1172 1175 1172 1175 <td xmlns:xlink="http://www.w3.org/1999/xlink">166</td>
###xml 1175 1178 1175 1178 <td xmlns:xlink="http://www.w3.org/1999/xlink">400</td>
###xml 1178 1178 1178 1178 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1178 1178 1178 1178 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1146 1178 1146 1178 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="3">Total number of haplotypes</td><td>166</td><td>400</td><td/><td/></tr>
###xml 979 1178 979 1178 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>Hap 1</td><td>A</td><td>C</td><td>109 (65.7)</td><td>221 (55.3)</td><td>1.549 (1.063&#8211;2.256)</td><td>0.023</td></tr><tr><td>Hap 2</td><td>G</td><td>A</td><td>37 (22.3)</td><td>135 (33.7)</td><td>0.563 (0.370&#8211;0.857)</td><td>0.007</td></tr><tr><td>Hap 3</td><td>G</td><td>C</td><td>20 (12.0)</td><td>41 (10.3)</td><td>1.199 (0.680&#8211;2.117)</td><td>0.530</td></tr><tr><td>Hap 4</td><td>A</td><td>A</td><td>0</td><td>3 (0.7)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td colspan="3">Total number of haplotypes</td><td>166</td><td>400</td><td/><td/></tr></tbody>
###xml 875 1178 875 1178 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">Haplotype</th><th colspan="2">SNP</th><th colspan="2">Number (%) of haplotypes in</th><th colspan="2">Haplotype comparison<sup>a</sup></th></tr><tr><th>rs280519</th><th>rs2304256</th><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>Hap 1</td><td>A</td><td>C</td><td>109 (65.7)</td><td>221 (55.3)</td><td>1.549 (1.063&#8211;2.256)</td><td>0.023</td></tr><tr><td>Hap 2</td><td>G</td><td>A</td><td>37 (22.3)</td><td>135 (33.7)</td><td>0.563 (0.370&#8211;0.857)</td><td>0.007</td></tr><tr><td>Hap 3</td><td>G</td><td>C</td><td>20 (12.0)</td><td>41 (10.3)</td><td>1.199 (0.680&#8211;2.117)</td><td>0.530</td></tr><tr><td>Hap 4</td><td>A</td><td>A</td><td>0</td><td>3 (0.7)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td colspan="3">Total number of haplotypes</td><td>166</td><td>400</td><td/><td/></tr></tbody></table>
###xml 1178 1180 1178 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1193 1195 1193 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 1178 1215 1178 1215 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="52"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p>
###xml 1215 1216 1215 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1215 1309 1215 1309 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="53"><sup>a</sup>Each haplotype was compared to other haplotypes combined using a logistic regression analysis</p>
###xml 1178 1309 1178 1309 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="52"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p><p textid="53"><sup>a</sup>Each haplotype was compared to other haplotypes combined using a logistic regression analysis</p></table-wrap-foot>
###xml 791 1309 791 1309 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab4"><label>Table IV</label><caption><p textid="51">Distributions of Haplotypes of <italic>TYK2</italic> Between CD Patients and Control Subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Haplotype</th><th colspan="2">SNP</th><th colspan="2">Number (%) of haplotypes in</th><th colspan="2">Haplotype comparison<sup>a</sup></th></tr><tr><th>rs280519</th><th>rs2304256</th><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>Hap 1</td><td>A</td><td>C</td><td>109 (65.7)</td><td>221 (55.3)</td><td>1.549 (1.063&#8211;2.256)</td><td>0.023</td></tr><tr><td>Hap 2</td><td>G</td><td>A</td><td>37 (22.3)</td><td>135 (33.7)</td><td>0.563 (0.370&#8211;0.857)</td><td>0.007</td></tr><tr><td>Hap 3</td><td>G</td><td>C</td><td>20 (12.0)</td><td>41 (10.3)</td><td>1.199 (0.680&#8211;2.117)</td><td>0.530</td></tr><tr><td>Hap 4</td><td>A</td><td>A</td><td>0</td><td>3 (0.7)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td colspan="3">Total number of haplotypes</td><td>166</td><td>400</td><td/><td/></tr></tbody></table><table-wrap-foot><p textid="52"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p><p textid="53"><sup>a</sup>Each haplotype was compared to other haplotypes combined using a logistic regression analysis</p></table-wrap-foot></table-wrap>
###xml 473 481 <span type="species:ncbi:9606">patients</span>
###xml 698 706 <span type="species:ncbi:9606">patients</span>
###xml 846 854 <span type="species:ncbi:9606">Patients</span>
Subsequently, four haplotypes composed of these two tag SNPs (rs280519 and rs2304256), which displayed a significant association with CD susceptibility and were located within the same linkage disequilibrium block, were constructed and identified using the SNP Alyze 7.0 standard software package (Table IV). A logistic regression analysis revealed the frequency of a Hap 1 haplotype (A allele at rs280519 SNP and C allele at rs2304256 SNP) to significantly increase in CD patients in comparison to that in control subjects (65.7% vs. 55.3%, P = 0.023, OR = 1.549). In contrast, the frequency of a Hap 2 haplotype (G allele at rs280519 SNP and A at rs2304256 SNP) was significantly decreased in CD patients in comparison to that in control subjects (22.3% vs. 33.7%, P = 0.007, OR = 0.563). Table IVDistributions of Haplotypes of TYK2 Between CD Patients and Control SubjectsHaplotypeSNPNumber (%) of haplotypes inHaplotype comparisonars280519rs2304256CDControlOR (95% CI)P valueHap 1AC109 (65.7)221 (55.3)1.549 (1.063-2.256)0.023Hap 2GA37 (22.3)135 (33.7)0.563 (0.370-0.857)0.007Hap 3GC20 (12.0)41 (10.3)1.199 (0.680-2.117)0.530Hap 4AA03 (0.7)--Total number of haplotypes166400OR odds ratio, CI confidence intervalaEach haplotype was compared to other haplotypes combined using a logistic regression analysis
###end p 50
###begin p 51
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 47 55 <span type="species:ncbi:9606">Patients</span>
Distributions of Haplotypes of TYK2 Between CD Patients and Control Subjects
###end p 51
###begin p 52
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 15 17 15 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
OR odds ratio, CI confidence interval
###end p 52
###begin p 53
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aEach haplotype was compared to other haplotypes combined using a logistic regression analysis
###end p 53
###begin p 54
###xml 81 82 81 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab5" ref-type="table">V</xref>
###xml 273 274 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 450 451 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 545 549 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 749 750 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab5" ref-type="table">V</xref>
###xml 753 760 753 760 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table V</label>
###xml 791 795 791 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 760 836 760 836 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="55">Distributions of Diplotypes of <italic>TYK2</italic> Between CD Patients and Control Subjects</p>
###xml 760 836 760 836 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="55">Distributions of Diplotypes of <italic>TYK2</italic> Between CD Patients and Control Subjects</p></caption>
###xml 836 845 836 845 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Diplotype</th>
###xml 845 872 845 872 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Number (%) of diplotypes in</th>
###xml 892 893 892 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 872 893 872 893 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Diplotype comparison<sup>a</sup></th>
###xml 836 893 836 893 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">Diplotype</th><th colspan="2">Number (%) of diplotypes in</th><th colspan="2">Diplotype comparison<sup>a</sup></th></tr>
###xml 893 895 893 895 <th xmlns:xlink="http://www.w3.org/1999/xlink">CD</th>
###xml 895 902 895 902 <th xmlns:xlink="http://www.w3.org/1999/xlink">Control</th>
###xml 902 913 902 913 <th xmlns:xlink="http://www.w3.org/1999/xlink">OR (95% CI)</th>
###xml 913 914 913 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 913 920 913 920 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>P</italic> value</th>
###xml 893 920 893 920 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr>
###xml 836 920 836 920 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">Diplotype</th><th colspan="2">Number (%) of diplotypes in</th><th colspan="2">Diplotype comparison<sup>a</sup></th></tr><tr><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead>
###xml 920 931 920 931 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hap 1/Hap 1</td>
###xml 931 940 931 940 <td xmlns:xlink="http://www.w3.org/1999/xlink">37 (44.6)</td>
###xml 940 949 940 949 <td xmlns:xlink="http://www.w3.org/1999/xlink">61 (30.5)</td>
###xml 949 968 949 968 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.833 (1.082&#8211;3.105)</td>
###xml 968 973 968 973 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.024</td>
###xml 920 973 920 973 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Hap 1/Hap 1</td><td>37 (44.6)</td><td>61 (30.5)</td><td>1.833 (1.082&#8211;3.105)</td><td>0.024</td></tr>
###xml 973 984 973 984 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hap 1/Hap 2</td>
###xml 984 993 984 993 <td xmlns:xlink="http://www.w3.org/1999/xlink">20 (24.1)</td>
###xml 993 1002 993 1002 <td xmlns:xlink="http://www.w3.org/1999/xlink">73 (36.5)</td>
###xml 1002 1021 1002 1021 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.552 (0.309&#8211;0.986)</td>
###xml 1021 1026 1021 1026 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.045</td>
###xml 973 1026 973 1026 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Hap 1/Hap 2</td><td>20 (24.1)</td><td>73 (36.5)</td><td>0.552 (0.309&#8211;0.986)</td><td>0.045</td></tr>
###xml 1026 1037 1026 1037 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hap 1/Hap 3</td>
###xml 1037 1046 1037 1046 <td xmlns:xlink="http://www.w3.org/1999/xlink">15 (18.1)</td>
###xml 1046 1055 1046 1055 <td xmlns:xlink="http://www.w3.org/1999/xlink">24 (12.0)</td>
###xml 1055 1074 1055 1074 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.618 (0.801&#8211;3.268)</td>
###xml 1074 1079 1074 1079 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.180</td>
###xml 1026 1079 1026 1079 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Hap 1/Hap 3</td><td>15 (18.1)</td><td>24 (12.0)</td><td>1.618 (0.801&#8211;3.268)</td><td>0.180</td></tr>
###xml 1079 1090 1079 1090 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hap 1/Hap 4</td>
###xml 1090 1091 1090 1091 <td xmlns:xlink="http://www.w3.org/1999/xlink">0</td>
###xml 1091 1098 1091 1098 <td xmlns:xlink="http://www.w3.org/1999/xlink">2 (1.0)</td>
###xml 1098 1099 1098 1099 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 1099 1100 1099 1100 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 1079 1100 1079 1100 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Hap 1/Hap 4</td><td>0</td><td>2 (1.0)</td><td>&#8211;</td><td>&#8211;</td></tr>
###xml 1100 1111 1100 1111 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hap 2/Hap 2</td>
###xml 1111 1118 1111 1118 <td xmlns:xlink="http://www.w3.org/1999/xlink">6 (7.2)</td>
###xml 1118 1127 1118 1127 <td xmlns:xlink="http://www.w3.org/1999/xlink">23 (11.5)</td>
###xml 1127 1146 1127 1146 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.600 (0.235&#8211;1.531)</td>
###xml 1146 1151 1146 1151 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.285</td>
###xml 1100 1151 1100 1151 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Hap 2/Hap 2</td><td>6 (7.2)</td><td>23 (11.5)</td><td>0.600 (0.235&#8211;1.531)</td><td>0.285</td></tr>
###xml 1151 1162 1151 1162 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hap 2/Hap 3</td>
###xml 1162 1169 1162 1169 <td xmlns:xlink="http://www.w3.org/1999/xlink">5 (6.0)</td>
###xml 1169 1177 1169 1177 <td xmlns:xlink="http://www.w3.org/1999/xlink">15 (7.5)</td>
###xml 1177 1196 1177 1196 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.791 (0.278&#8211;2.251)</td>
###xml 1196 1201 1196 1201 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.660</td>
###xml 1151 1201 1151 1201 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Hap 2/Hap 3</td><td>5 (6.0)</td><td>15 (7.5)</td><td>0.791 (0.278&#8211;2.251)</td><td>0.660</td></tr>
###xml 1201 1212 1201 1212 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hap 2/Hap 4</td>
###xml 1212 1213 1212 1213 <td xmlns:xlink="http://www.w3.org/1999/xlink">0</td>
###xml 1213 1220 1213 1220 <td xmlns:xlink="http://www.w3.org/1999/xlink">1 (0.5)</td>
###xml 1220 1221 1220 1221 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 1221 1222 1221 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 1201 1222 1201 1222 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Hap 2/Hap 4</td><td>0</td><td>1 (0.5)</td><td>&#8211;</td><td>&#8211;</td></tr>
###xml 1222 1233 1222 1233 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hap 3/Hap 3</td>
###xml 1233 1234 1233 1234 <td xmlns:xlink="http://www.w3.org/1999/xlink">0</td>
###xml 1234 1241 1234 1241 <td xmlns:xlink="http://www.w3.org/1999/xlink">1 (0.5)</td>
###xml 1241 1242 1241 1242 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 1242 1243 1242 1243 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 1222 1243 1222 1243 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Hap 3/Hap 3</td><td>0</td><td>1 (0.5)</td><td>&#8211;</td><td>&#8211;</td></tr>
###xml 1243 1255 1243 1255 <td xmlns:xlink="http://www.w3.org/1999/xlink">Total number</td>
###xml 1255 1257 1255 1257 <td xmlns:xlink="http://www.w3.org/1999/xlink">83</td>
###xml 1257 1260 1257 1260 <td xmlns:xlink="http://www.w3.org/1999/xlink">200</td>
###xml 1260 1260 1260 1260 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1260 1260 1260 1260 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1243 1260 1243 1260 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Total number</td><td>83</td><td>200</td><td/><td/></tr>
###xml 920 1260 920 1260 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>Hap 1/Hap 1</td><td>37 (44.6)</td><td>61 (30.5)</td><td>1.833 (1.082&#8211;3.105)</td><td>0.024</td></tr><tr><td>Hap 1/Hap 2</td><td>20 (24.1)</td><td>73 (36.5)</td><td>0.552 (0.309&#8211;0.986)</td><td>0.045</td></tr><tr><td>Hap 1/Hap 3</td><td>15 (18.1)</td><td>24 (12.0)</td><td>1.618 (0.801&#8211;3.268)</td><td>0.180</td></tr><tr><td>Hap 1/Hap 4</td><td>0</td><td>2 (1.0)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Hap 2/Hap 2</td><td>6 (7.2)</td><td>23 (11.5)</td><td>0.600 (0.235&#8211;1.531)</td><td>0.285</td></tr><tr><td>Hap 2/Hap 3</td><td>5 (6.0)</td><td>15 (7.5)</td><td>0.791 (0.278&#8211;2.251)</td><td>0.660</td></tr><tr><td>Hap 2/Hap 4</td><td>0</td><td>1 (0.5)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Hap 3/Hap 3</td><td>0</td><td>1 (0.5)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Total number</td><td>83</td><td>200</td><td/><td/></tr></tbody>
###xml 836 1260 836 1260 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">Diplotype</th><th colspan="2">Number (%) of diplotypes in</th><th colspan="2">Diplotype comparison<sup>a</sup></th></tr><tr><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>Hap 1/Hap 1</td><td>37 (44.6)</td><td>61 (30.5)</td><td>1.833 (1.082&#8211;3.105)</td><td>0.024</td></tr><tr><td>Hap 1/Hap 2</td><td>20 (24.1)</td><td>73 (36.5)</td><td>0.552 (0.309&#8211;0.986)</td><td>0.045</td></tr><tr><td>Hap 1/Hap 3</td><td>15 (18.1)</td><td>24 (12.0)</td><td>1.618 (0.801&#8211;3.268)</td><td>0.180</td></tr><tr><td>Hap 1/Hap 4</td><td>0</td><td>2 (1.0)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Hap 2/Hap 2</td><td>6 (7.2)</td><td>23 (11.5)</td><td>0.600 (0.235&#8211;1.531)</td><td>0.285</td></tr><tr><td>Hap 2/Hap 3</td><td>5 (6.0)</td><td>15 (7.5)</td><td>0.791 (0.278&#8211;2.251)</td><td>0.660</td></tr><tr><td>Hap 2/Hap 4</td><td>0</td><td>1 (0.5)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Hap 3/Hap 3</td><td>0</td><td>1 (0.5)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Total number</td><td>83</td><td>200</td><td/><td/></tr></tbody></table>
###xml 1260 1262 1260 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 1275 1277 1275 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 1260 1297 1260 1297 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="56"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p>
###xml 1297 1298 1297 1298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1297 1391 1297 1391 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="57"><sup>a</sup>Each diplotype was compared to other diplotypes combined using a logistic regression analysis</p>
###xml 1260 1391 1260 1391 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="56"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p><p textid="57"><sup>a</sup>Each diplotype was compared to other diplotypes combined using a logistic regression analysis</p></table-wrap-foot>
###xml 753 1391 753 1391 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab5"><label>Table V</label><caption><p textid="55">Distributions of Diplotypes of <italic>TYK2</italic> Between CD Patients and Control Subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Diplotype</th><th colspan="2">Number (%) of diplotypes in</th><th colspan="2">Diplotype comparison<sup>a</sup></th></tr><tr><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>Hap 1/Hap 1</td><td>37 (44.6)</td><td>61 (30.5)</td><td>1.833 (1.082&#8211;3.105)</td><td>0.024</td></tr><tr><td>Hap 1/Hap 2</td><td>20 (24.1)</td><td>73 (36.5)</td><td>0.552 (0.309&#8211;0.986)</td><td>0.045</td></tr><tr><td>Hap 1/Hap 3</td><td>15 (18.1)</td><td>24 (12.0)</td><td>1.618 (0.801&#8211;3.268)</td><td>0.180</td></tr><tr><td>Hap 1/Hap 4</td><td>0</td><td>2 (1.0)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Hap 2/Hap 2</td><td>6 (7.2)</td><td>23 (11.5)</td><td>0.600 (0.235&#8211;1.531)</td><td>0.285</td></tr><tr><td>Hap 2/Hap 3</td><td>5 (6.0)</td><td>15 (7.5)</td><td>0.791 (0.278&#8211;2.251)</td><td>0.660</td></tr><tr><td>Hap 2/Hap 4</td><td>0</td><td>1 (0.5)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Hap 3/Hap 3</td><td>0</td><td>1 (0.5)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Total number</td><td>83</td><td>200</td><td/><td/></tr></tbody></table><table-wrap-foot><p textid="56"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p><p textid="57"><sup>a</sup>Each diplotype was compared to other diplotypes combined using a logistic regression analysis</p></table-wrap-foot></table-wrap>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
###xml 334 342 <span type="species:ncbi:9606">patients</span>
###xml 613 621 <span type="species:ncbi:9606">patients</span>
###xml 807 815 <span type="species:ncbi:9606">Patients</span>
Furthermore, eight diplotypes composed of four haplotypes were identified (Table V). A logistic regression analysis showed that the frequency of the CD patients possessing a Hap 1/Hap 1 diplotype was significantly higher than that of the control subjects (44.6% vs. 30.5%, P = 0.024, OR = 1.833). In contrast, the frequency of the CD patients having a Hap 1/Hap 2 diplotype was significantly lower than that of the control subjects (24.1% vs. 36.5%, P = 0.045, OR = 0.552). The results of the diplotype analysis regarding the Hap 1 haplotype of TYK2 coincided well with those of the haplotype analysis between CD patients and control subjects; however, a Hap 2/Hap 2 diplotype showed no statistically significant lack of susceptibility to CD (Table V). Table VDistributions of Diplotypes of TYK2 Between CD Patients and Control SubjectsDiplotypeNumber (%) of diplotypes inDiplotype comparisonaCDControlOR (95% CI)P valueHap 1/Hap 137 (44.6)61 (30.5)1.833 (1.082-3.105)0.024Hap 1/Hap 220 (24.1)73 (36.5)0.552 (0.309-0.986)0.045Hap 1/Hap 315 (18.1)24 (12.0)1.618 (0.801-3.268)0.180Hap 1/Hap 402 (1.0)--Hap 2/Hap 26 (7.2)23 (11.5)0.600 (0.235-1.531)0.285Hap 2/Hap 35 (6.0)15 (7.5)0.791 (0.278-2.251)0.660Hap 2/Hap 401 (0.5)--Hap 3/Hap 301 (0.5)--Total number83200OR odds ratio, CI confidence intervalaEach diplotype was compared to other diplotypes combined using a logistic regression analysis
###end p 54
###begin p 55
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 47 55 <span type="species:ncbi:9606">Patients</span>
Distributions of Diplotypes of TYK2 Between CD Patients and Control Subjects
###end p 55
###begin p 56
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 15 17 15 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
OR odds ratio, CI confidence interval
###end p 56
###begin p 57
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aEach diplotype was compared to other diplotypes combined using a logistic regression analysis
###end p 57
###begin title 58
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
Gene-Gene Interaction Between STAT3 and TYK2 for Susceptibility to CD
###end title 58
###begin p 59
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 230 235 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 326 327 326 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 374 375 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab6" ref-type="table">VI</xref>
###xml 444 452 444 452 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table VI</label>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 501 505 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 452 540 452 540 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="60">Gene&#8211;Gene Interaction Between <italic>STAT3</italic> Genotype and <italic>TYK2</italic> Diplotype for Susceptibility to CD</p>
###xml 452 540 452 540 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="60">Gene&#8211;Gene Interaction Between <italic>STAT3</italic> Genotype and <italic>TYK2</italic> Diplotype for Susceptibility to CD</p></caption>
###xml 540 546 540 546 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Factor</th>
###xml 563 564 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 546 564 546 564 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Factor comparison<sup>a</sup></th>
###xml 540 564 540 564 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">Factor</th><th colspan="2">Factor comparison<sup>a</sup></th></tr>
###xml 564 575 564 575 <th xmlns:xlink="http://www.w3.org/1999/xlink">OR (95% CI)</th>
###xml 575 576 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 575 582 575 582 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>P</italic> value</th>
###xml 564 582 564 582 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr>
###xml 540 582 540 582 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">Factor</th><th colspan="2">Factor comparison<sup>a</sup></th></tr><tr><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead>
###xml 611 616 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 582 616 582 616 <td xmlns:xlink="http://www.w3.org/1999/xlink">C/C genotype at rs2293152 in <italic>STAT3</italic></td>
###xml 616 635 616 635 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3.113 (1.515&#8211;6.399)</td>
###xml 635 640 635 640 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.002</td>
###xml 582 640 582 640 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>C/C genotype at rs2293152 in <italic>STAT3</italic></td><td char="(" align="char">3.113 (1.515&#8211;6.399)</td><td char="." align="char">0.002</td></tr>
###xml 665 669 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 640 669 640 669 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hap 1/Hap 1 diplotype of <italic>TYK2</italic></td>
###xml 669 688 669 688 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.783 (1.042&#8211;3.053)</td>
###xml 688 693 688 693 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.030</td>
###xml 640 693 640 693 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Hap 1/Hap 1 diplotype of <italic>TYK2</italic></td><td char="(" align="char">1.783 (1.042&#8211;3.053)</td><td char="." align="char">0.030</td></tr>
###xml 582 693 582 693 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>C/C genotype at rs2293152 in <italic>STAT3</italic></td><td char="(" align="char">3.113 (1.515&#8211;6.399)</td><td char="." align="char">0.002</td></tr><tr><td>Hap 1/Hap 1 diplotype of <italic>TYK2</italic></td><td char="(" align="char">1.783 (1.042&#8211;3.053)</td><td char="." align="char">0.030</td></tr></tbody>
###xml 540 693 540 693 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">Factor</th><th colspan="2">Factor comparison<sup>a</sup></th></tr><tr><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>C/C genotype at rs2293152 in <italic>STAT3</italic></td><td char="(" align="char">3.113 (1.515&#8211;6.399)</td><td char="." align="char">0.002</td></tr><tr><td>Hap 1/Hap 1 diplotype of <italic>TYK2</italic></td><td char="(" align="char">1.783 (1.042&#8211;3.053)</td><td char="." align="char">0.030</td></tr></tbody></table>
###xml 693 695 693 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 708 710 708 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 693 730 693 730 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="61"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p>
###xml 730 731 730 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 730 813 730 813 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="62"><sup>a</sup>Factors were statistically analyzed by a multivariate logistic regression analysis</p>
###xml 693 813 693 813 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="61"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p><p textid="62"><sup>a</sup>Factors were statistically analyzed by a multivariate logistic regression analysis</p></table-wrap-foot>
###xml 444 813 444 813 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab6"><label>Table VI</label><caption><p textid="60">Gene&#8211;Gene Interaction Between <italic>STAT3</italic> Genotype and <italic>TYK2</italic> Diplotype for Susceptibility to CD</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Factor</th><th colspan="2">Factor comparison<sup>a</sup></th></tr><tr><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>C/C genotype at rs2293152 in <italic>STAT3</italic></td><td char="(" align="char">3.113 (1.515&#8211;6.399)</td><td char="." align="char">0.002</td></tr><tr><td>Hap 1/Hap 1 diplotype of <italic>TYK2</italic></td><td char="(" align="char">1.783 (1.042&#8211;3.053)</td><td char="." align="char">0.030</td></tr></tbody></table><table-wrap-foot><p textid="61"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p><p textid="62"><sup>a</sup>Factors were statistically analyzed by a multivariate logistic regression analysis</p></table-wrap-foot></table-wrap>
###xml 73 81 <span type="species:ncbi:9606">patients</span>
The gene-gene interaction between STAT3 and TYK2 was analyzed between CD patients and control subjects. A multivariate logistic regression analysis indicated that two variable genetic factors, the C/C genotype at rs2293152 SNP in STAT3 and the Hap 1/Hap 1 diplotype of TYK2, independently contributed to susceptibility to CD (P = 0.002, OR = 3.113, 95% CI = 1.515-6.399 and P = 0.030, OR = 1.783, 95% CI = 1.042-3.053, respectively; Table VI). Table VIGene-Gene Interaction Between STAT3 Genotype and TYK2 Diplotype for Susceptibility to CDFactorFactor comparisonaOR (95% CI)P valueC/C genotype at rs2293152 in STAT33.113 (1.515-6.399)0.002Hap 1/Hap 1 diplotype of TYK21.783 (1.042-3.053)0.030OR odds ratio, CI confidence intervalaFactors were statistically analyzed by a multivariate logistic regression analysis
###end p 59
###begin p 60
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
Gene-Gene Interaction Between STAT3 Genotype and TYK2 Diplotype for Susceptibility to CD
###end p 60
###begin p 61
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 15 17 15 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
OR odds ratio, CI confidence interval
###end p 61
###begin p 62
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aFactors were statistically analyzed by a multivariate logistic regression analysis
###end p 62
###begin p 63
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 216 217 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 362 366 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 446 449 446 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab7" ref-type="table">VII</xref>
###xml 452 461 452 461 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table VII</label>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 516 520 516 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 461 555 461 555 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="64">The Gene&#8211;Gene Combination Effect of <italic>STAT3</italic> Genotype and <italic>TYK2</italic> Diplotype for Susceptibility to CD</p>
###xml 461 555 461 555 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="64">The Gene&#8211;Gene Combination Effect of <italic>STAT3</italic> Genotype and <italic>TYK2</italic> Diplotype for Susceptibility to CD</p></caption>
###xml 555 561 555 561 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Factor</th>
###xml 561 574 561 574 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Number (%) of</th>
###xml 591 592 591 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 574 592 574 592 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Factor comparison<sup>a</sup></th>
###xml 555 592 555 592 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">Factor</th><th colspan="2">Number (%) of</th><th colspan="2">Factor comparison<sup>a</sup></th></tr>
###xml 592 594 592 594 <th xmlns:xlink="http://www.w3.org/1999/xlink">CD</th>
###xml 594 601 594 601 <th xmlns:xlink="http://www.w3.org/1999/xlink">Control</th>
###xml 601 612 601 612 <th xmlns:xlink="http://www.w3.org/1999/xlink">OR (95% CI)</th>
###xml 612 613 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 612 619 612 619 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>P</italic> value</th>
###xml 592 619 592 619 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr>
###xml 555 619 555 619 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">Factor</th><th colspan="2">Number (%) of</th><th colspan="2">Factor comparison<sup>a</sup></th></tr><tr><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead>
###xml 648 653 648 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 673 677 673 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 619 677 619 677 <td xmlns:xlink="http://www.w3.org/1999/xlink">C/C genotype at rs2293152 in <italic>STAT3</italic> and Hap 1/Hap 1 of <italic>TYK2</italic></td>
###xml 677 686 677 686 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11 (13.3)</td>
###xml 686 693 686 693 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4 (2.0)</td>
###xml 693 713 693 713 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char" rowspan="2">7.486 (2.310&#8211;24.261)</td>
###xml 713 719 713 719 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char" rowspan="2">0.0008</td>
###xml 619 719 619 719 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>C/C genotype at rs2293152 in <italic>STAT3</italic> and Hap 1/Hap 1 of <italic>TYK2</italic></td><td char="(" align="char">11 (13.3)</td><td char="(" align="char">4 (2.0)</td><td char="(" align="char" rowspan="2">7.486 (2.310&#8211;24.261)</td><td char="." align="char" rowspan="2">0.0008</td></tr>
###xml 719 734 719 734 <td xmlns:xlink="http://www.w3.org/1999/xlink">Other genotypes</td>
###xml 734 743 734 743 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">72 (86.7)</td>
###xml 743 753 743 753 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">196 (98.0)</td>
###xml 719 753 719 753 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Other genotypes</td><td char="(" align="char">72 (86.7)</td><td char="(" align="char">196 (98.0)</td></tr>
###xml 619 753 619 753 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>C/C genotype at rs2293152 in <italic>STAT3</italic> and Hap 1/Hap 1 of <italic>TYK2</italic></td><td char="(" align="char">11 (13.3)</td><td char="(" align="char">4 (2.0)</td><td char="(" align="char" rowspan="2">7.486 (2.310&#8211;24.261)</td><td char="." align="char" rowspan="2">0.0008</td></tr><tr><td>Other genotypes</td><td char="(" align="char">72 (86.7)</td><td char="(" align="char">196 (98.0)</td></tr></tbody>
###xml 555 753 555 753 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">Factor</th><th colspan="2">Number (%) of</th><th colspan="2">Factor comparison<sup>a</sup></th></tr><tr><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>C/C genotype at rs2293152 in <italic>STAT3</italic> and Hap 1/Hap 1 of <italic>TYK2</italic></td><td char="(" align="char">11 (13.3)</td><td char="(" align="char">4 (2.0)</td><td char="(" align="char" rowspan="2">7.486 (2.310&#8211;24.261)</td><td char="." align="char" rowspan="2">0.0008</td></tr><tr><td>Other genotypes</td><td char="(" align="char">72 (86.7)</td><td char="(" align="char">196 (98.0)</td></tr></tbody></table>
###xml 753 755 753 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 768 770 768 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 753 790 753 790 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="65"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p>
###xml 790 791 790 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 790 873 790 873 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="66"><sup>a</sup>Factors were statistically analyzed by a multivariate logistic regression analysis</p>
###xml 753 873 753 873 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="65"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p><p textid="66"><sup>a</sup>Factors were statistically analyzed by a multivariate logistic regression analysis</p></table-wrap-foot>
###xml 452 873 452 873 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab7"><label>Table VII</label><caption><p textid="64">The Gene&#8211;Gene Combination Effect of <italic>STAT3</italic> Genotype and <italic>TYK2</italic> Diplotype for Susceptibility to CD</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Factor</th><th colspan="2">Number (%) of</th><th colspan="2">Factor comparison<sup>a</sup></th></tr><tr><th>CD</th><th>Control</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>C/C genotype at rs2293152 in <italic>STAT3</italic> and Hap 1/Hap 1 of <italic>TYK2</italic></td><td char="(" align="char">11 (13.3)</td><td char="(" align="char">4 (2.0)</td><td char="(" align="char" rowspan="2">7.486 (2.310&#8211;24.261)</td><td char="." align="char" rowspan="2">0.0008</td></tr><tr><td>Other genotypes</td><td char="(" align="char">72 (86.7)</td><td char="(" align="char">196 (98.0)</td></tr></tbody></table><table-wrap-foot><p textid="65"><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p><p textid="66"><sup>a</sup>Factors were statistically analyzed by a multivariate logistic regression analysis</p></table-wrap-foot></table-wrap>
Furthermore, with regard to the gene-gene combination effect of STAT3 genotype and TYK2 diplotype for susceptibility to CD, a multivariate logistic regression analysis showed the OR to significantly increase (7.486, P = 0.0008, 95% CI = 2.310-24.261) in the individuals possessing both the C/C genotype at rs2293152 SNP in STAT3 and the Hap 1/Hap 1 diplotype of TYK2 in comparison to that in the individuals possessing the other genotypes (Table VII). Table VIIThe Gene-Gene Combination Effect of STAT3 Genotype and TYK2 Diplotype for Susceptibility to CDFactorNumber (%) ofFactor comparisonaCDControlOR (95% CI)P valueC/C genotype at rs2293152 in STAT3 and Hap 1/Hap 1 of TYK211 (13.3)4 (2.0)7.486 (2.310-24.261)0.0008Other genotypes72 (86.7)196 (98.0)OR odds ratio, CI confidence intervalaFactors were statistically analyzed by a multivariate logistic regression analysis
###end p 63
###begin p 64
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
The Gene-Gene Combination Effect of STAT3 Genotype and TYK2 Diplotype for Susceptibility to CD
###end p 64
###begin p 65
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OR</italic>
###xml 15 17 15 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
OR odds ratio, CI confidence interval
###end p 65
###begin p 66
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aFactors were statistically analyzed by a multivariate logistic regression analysis
###end p 66
###begin title 67
Discussion
###end title 67
###begin p 68
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 218 223 218 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 228 232 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 577 578 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
This study is the first demonstration of the single-marker association of STAT3 and TYK2 polymorphisms with CD susceptibility in the Japanese population, although meta-analyses using GWA data previously indicated that STAT3 and TYK2 appear to be the genetic determinants of CD in the European and North American populations [9, 10, 14]. Furthermore, STAT3 is associated with only CD, but not UC, in the Japanese population by a candidate gene-based association study, thereby supporting the meta-analysis of the GWA data in populations of European and North American ancestry [9].
###end p 68
###begin p 69
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 421 422 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 717 722 717 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 824 832 <span type="species:ncbi:9606">patients</span>
The presence of the C allele and its homozygous C/C genotype at rs2293152 SNP in STAT3 conferred susceptibility to CD. CD- and UC-susceptible rs744166 SNP, which was identified by GWA studies [9, 12, 14], was not analyzed in this study because this SNP was not selected as a genotyped tag SNP by the iHap software program. Because rs744166 and rs957970 SNPs are located within the same linkage disequilibrium block (Fig. 1) and rs957970 SNP was not associated with susceptibility to CD in this study, rs744166 SNP may not be associated with CD in the Japanese population. The difference in susceptibility to CD at the SNP site between Caucasian and Japanese subjects can be attributed to genetic background, although STAT3 may contribute to the same mechanisms of the immunopathogenesis of CD in both Caucasian and Japanese patients.
###end p 69
###begin p 70
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 237 241 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 287 291 287 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 717 718 717 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1031 1035 1031 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 1116 1124 <span type="species:ncbi:9606">patients</span>
The presence of the A allele and its homozygous A/A genotype at rs280519 SNP in TYK2, the C allele and its homozygous C/C genotype at rs2304256 SNP in TYK2, the Hap 1 haplotype (A allele at rs280519 SNP and C allele at rs2304256 SNP) of TYK2, and its homozygous Hap 1/Hap 1 diplotype of TYK2 showed susceptibility to CD. CD-susceptible rs12720356 SNP, which was identified by GWA studies [10], was not analyzed in this study because this SNP was not selected as a genotyped tag SNP by the iHap software program. Although rs280519 and rs2304256 SNPs, which were examined in this study, are located within the same linkage disequilibrium block, rs12720356 SNP does not belong to any linkage disequilibrium blocks (Fig. 2). Furthermore, because rs280496 SNP, nearby rs12720356 SNP, was not associated with susceptibility to CD in this study, rs12720356 SNP may thus not be associated with CD in the Japanese population. This disparity can be also attributed to genetic differences between Caucasian and Japanese individuals, although TYK2 may contribute to the same immunopathogenesis in both Caucasian and Japanese CD patients.
###end p 70
###begin p 71
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 389 392 389 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab7" ref-type="table">VII</xref>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 470 474 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 777 782 777 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 787 791 787 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 318 326 <span type="species:ncbi:9606">patients</span>
In addition, the presence of both the C/C genotype at rs2293152 in STAT3 and the Hap 1/Hap 1 diplotype of TYK2 independently contributed to the pathogenesis of CD and remarkably increased the odds ratio for CD, thus indicating an approximately 7.5-fold increase in susceptibility to CD in this study, although such CD patients account for only approximately 13% (11 of 83 = 13.3% in Table VII) of the genetic variance observed in CD. These findings imply that STAT3 and TYK2 are genetic determinants for the predisposition to the onset and/or development of CD in Japanese individuals. However, this study population was relatively small, and further studies on a larger number of Japanese subjects and on other ethnicities are necessary to confirm the association between the STAT3 and TYK2 polymorphisms and CD. Additional studies are needed because different populations will often have different allele frequencies and haplotype structures.
###end p 71
###begin p 72
###xml 26 37 26 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-23/IL23R</italic>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 522 523 522 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">41</xref>
###xml 1092 1097 1092 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 1102 1106 1102 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 1152 1157 1152 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 1191 1195 1191 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 861 869 <span type="species:ncbi:9606">patients</span>
Recent GWA studies on the IL-23/IL23R signaling pathway have shifted the focus to the IL-23 cytokine [6-12]. After IL-23 binds to the receptor, which comprises IL23R and IL12RB1 [35], IL-23 signaling may induce the activation of JAK2 in IL23R as well as TYK2 in IL12RB1 because the IL-12RB1 and IL-23R require TYK2 [16], thus resulting in the phosphorylation of STAT3 as well as STAT1, STAT4, and STAT5 in activated macrophages and dendritic cells [35]. The signaling cascade eventually leads to the differentiation of CD4+ (naive) T cells into Th17 cells [17, 20-22]. Th17 cells produce IL-17A, IL-17F, and IL-22, which are involved in the first line of the host defense by controlling the immune responses [22]. Indeed, the expression of IL-12, IL-23, STAT3, IL-17, and IL-22 has been reported to increase in the lamina propria of the intestinal mucosa in CD patients [36-41]. Taken together, the IL-23/IL23R signaling pathway is central to the inflammation leading to CD and modifies an individual's risk of developing CD. For these reasons, it may be speculated that the polymorphisms of STAT3 and TYK2, especially the C/C genotype at rs2293152 in STAT3 and the Hap 1/Hap 1 diplotype of TYK2, may affect the gain-of-function of both STAT3 and TYK2, thus altering the efficiency of the IL-23/IL23R signaling pathway. These changes can lead to the perpetuation of the chronic intestinal inflammatory process, thereby resulting in the onset and/or development of CD.
###end p 72
###begin title 73
Conclusions
###end title 73
###begin p 74
###xml 3 7 3 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 257 262 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT3</italic>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TYK2</italic>
As TYK2 and STAT3 appear to be the genetic determinants of CD in the Japanese population, the combination polymorphism of TYK2 and STAT3 may be useful as a new DNA-based diagnostic biomarker for identifying high-risk individuals susceptible to CD. Finally, STAT3 and TYK2 may be good target molecules for the development of novel drugs in the future.
###end p 74
###begin p 75
###xml 35 43 <span type="species:ncbi:9606">patients</span>
We are grateful to the physicians, patients, and volunteers who participated in this study. This work was supported by a research grant from the Non Profit Organization Aimed to Support Community Medicine Research in Nagasaki.
###end p 75
###begin p 76
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 76
###begin title 77
References
###end title 77
###begin article-title 78
Inflammatory bowel disease: etiology and pathogenesis
###end article-title 78
###begin article-title 79
Inflammatory bowel disease
###end article-title 79
###begin article-title 80
Unravelling the pathogenesis of inflammatory bowel disease
###end article-title 80
###begin article-title 81
The genetics and immunopathogenesis of inflammatory bowel disease
###end article-title 81
###begin article-title 82
GWA studies: rewriting the story of IBD
###end article-title 82
###begin article-title 83
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL23R</italic>
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
###end article-title 83
###begin article-title 84
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis
###end article-title 84
###begin article-title 85
Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls
###end article-title 85
###begin article-title 86
Genome-wide association study defines more than 30 distinct susceptibility loci for Crohn's disease
###end article-title 86
###begin article-title 87
Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn disease
###end article-title 87
###begin article-title 88
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ECM1</italic>
Genetic determinants of ulcerative colitis induce the ECM1 locus and five loci implicated in Crohn's disease
###end article-title 88
###begin article-title 89
Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis
###end article-title 89
###begin article-title 90
IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease
###end article-title 90
###begin article-title 91
Sequence variants in IL10, APRC2 and multiple other loci contribute to ulcerative colitis susceptibility
###end article-title 91
###begin article-title 92
Tyk2 plays a restricted role in IFNalpha signaling, although it is required for IL-12-mediated T cell function
###end article-title 92
###begin article-title 93
The JAK-STAT signaling pathways: input and output integration
###end article-title 93
###begin article-title 94
Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4
###end article-title 94
###begin article-title 95
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
###end article-title 95
###begin article-title 96
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity
###end article-title 96
###begin article-title 97
###xml 12 14 12 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink">17</sub>
The IL-23/Th17 axis: therapeutic targets for autoimmune inflammation
###end article-title 97
###begin article-title 98
Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion
###end article-title 98
###begin article-title 99
###xml 63 79 63 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 63 79 <span type="species:ncbi:562">Escherichia coli</span>
Tyk2-signaling plays an important role in host defense against Escherichia coli through IL-23-induced IL-17 production by gammadelta T cells
###end article-title 99
###begin article-title 100
Classification of inflammatory bowel disease
###end article-title 100
###begin article-title 101
Inflammatory bowel disease (1)
###end article-title 101
###begin article-title 102
Inflammatory bowel disease (2)
###end article-title 102
###begin article-title 103
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
###end article-title 103
###begin article-title 104
Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial
###end article-title 104
###begin article-title 105
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
###end article-title 105
###begin article-title 106
Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway
###end article-title 106
###begin article-title 107
tyk2, prototype of a novel class of non-receptor tyrosine kinase genes
###end article-title 107
###begin article-title 108
###xml 20 25 <span type="species:ncbi:9606">human</span>
A second generation human haplotype map of over 3.1 million SNPs
###end article-title 108
###begin article-title 109
iHAP-integrated haplotype analysis pipeline for characterizing the haplotype structure of genes
###end article-title 109
###begin article-title 110
###xml 43 48 <span type="species:ncbi:9606">human</span>
High-resolution haplotype structure in the human genome
###end article-title 110
###begin article-title 111
Haplotype tagging for the identification of common disease genes
###end article-title 111
###begin article-title 112
A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R
###end article-title 112
###begin article-title 113
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 176 183 176 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo
###end article-title 113
###begin article-title 114
Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis
###end article-title 114
###begin article-title 115
Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases
###end article-title 115
###begin article-title 116
Both iL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12p40 monoclonal antibody
###end article-title 116
###begin article-title 117
IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease
###end article-title 117
###begin article-title 118
IL-23/IL-17 immunity as a hallmark of Crohn's disease
###end article-title 118

